<?xml version="1.0" ?>
<!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd">

<pmc-articleset><article article-type="review-article" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">
<?properties open_access?>
<front>
<journal-meta>
<journal-id journal-id-type="nlm-ta">Front Pediatr</journal-id>
<journal-id journal-id-type="iso-abbrev">Front Pediatr</journal-id>
<journal-id journal-id-type="publisher-id">Front. Pediatr.</journal-id>
<journal-title-group>
<journal-title>Frontiers in Pediatrics</journal-title>
</journal-title-group>
<issn pub-type="epub">2296-2360</issn>
<publisher>
<publisher-name>Frontiers Media S.A.</publisher-name>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="pmid">32047730</article-id>
<article-id pub-id-type="pmc">6997472</article-id>
<article-id pub-id-type="doi">10.3389/fped.2020.00005</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Pediatrics</subject>
<subj-group>
<subject>Mini Review</subject>
</subj-group>
</subj-group>
</article-categories>
<title-group>
<article-title>Advantages and Limitations of the Neonatal Immune System</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name>
<surname>Tsafaras</surname>
<given-names>George P.</given-names>
</name>
<xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref>
<uri xlink:href="http://loop.frontiersin.org/people/818417/overview" xlink:type="simple"></uri>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Ntontsi</surname>
<given-names>Polyxeni</given-names>
</name>
<xref ref-type="aff" rid="aff2">
<sup>2</sup>
</xref>
<uri xlink:href="http://loop.frontiersin.org/people/887493/overview" xlink:type="simple"></uri>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Xanthou</surname>
<given-names>Georgina</given-names>
</name>
<xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref>
<xref ref-type="corresp" rid="c001">
<sup>*</sup>
</xref>
<uri xlink:href="http://loop.frontiersin.org/people/717674/overview" xlink:type="simple"></uri>
</contrib>
</contrib-group>
<aff id="aff1"><sup>1</sup><institution>Cellular Immunology Lab, Center for Basic Research, Biomedical Research Foundation of the Academy of Athens</institution>, <addr-line>Athens</addr-line>, <country>Greece</country></aff>
<aff id="aff2"><sup>2</sup><institution>Second Respiratory Medicine Department, ‘Attikon’ University Hospital, National and Kapodistrian University of Athens, Medical School</institution>, <addr-line>Athens</addr-line>, <country>Greece</country></aff>
<author-notes>
<fn fn-type="edited-by">
<p>Edited by: Vassiliki Papaevangelou, National and Kapodistrian University of Athens, Greece</p>
</fn>
<fn fn-type="edited-by">
<p>Reviewed by: Riccardo Castagnoli, University of Pavia, Italy; Stefan Winkler, Dresden University of Technology, Germany</p>
</fn>
<corresp id="c001">*Correspondence: Georgina Xanthou <email>gxanthou@bioacademy.gr</email></corresp>
<fn fn-type="other" id="fn001">
<p>This article was submitted to Pediatric Immunology, a section of the journal Frontiers in Pediatrics</p>
</fn>
</author-notes>
<pub-date pub-type="epub">
<day>28</day>
<month>1</month>
<year>2020</year>
</pub-date>
<pub-date pub-type="collection">
<year>2020</year>
</pub-date>
<volume>8</volume>
<elocation-id>5</elocation-id>
<history>
<date date-type="received">
<day>01</day>
<month>9</month>
<year>2019</year>
</date>
<date date-type="accepted">
<day>07</day>
<month>1</month>
<year>2020</year>
</date>
</history>
<permissions>
<copyright-statement>Copyright © 2020 Tsafaras, Ntontsi and Xanthou.</copyright-statement>
<copyright-year>2020</copyright-year>
<copyright-holder>Tsafaras, Ntontsi and Xanthou</copyright-holder>
<license xlink:href="http://creativecommons.org/licenses/by/4.0/">
<license-p>This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.</license-p>
</license>
</permissions>
<abstract>
<p>During early post-natal life, neonates must adjust to the transition from the sheltered intra-uterine environment to the microbe-laden external world, wherein they encounter a constellation of antigens and the colonization by the microbiome. At this vulnerable stage, neonatal immune responses are considered immature and present significant differences to those of adults. Pertinent to innate immunity, functional and quantitative deficiencies in antigen-presenting cells and phagocytes are often documented. Exposure to environmental antigens and microbial colonization is associated with epigenetic immune cell reprogramming and activation of effector and regulatory mechanisms that ensure age-depended immune system maturation and prevention of tissue damage. Moreover, neonatal innate immune memory has emerged as a critical mechanism providing protection against infectious agents. Still, in neonates, inexperience to antigenic exposure, along with enhancement of tissue-protective immunosuppressive mechanisms are often associated with severe immunopathological conditions, including sepsis and neurodevelopmental disorders. Despite significant advances in the field, adequate vaccination in newborns is still in its infancy due to elemental restrictions associated also with defective immune responses. In this review, we provide an overview of neonatal innate immune cells, highlighting phenotypic and functional disparities with their adult counterparts. We also discuss the effects of epigenetic modifications and microbial colonization on the regulation of neonatal immunity. A recent update on mechanisms underlying dysregulated neonatal innate immunity and linked infectious and neurodevelopmental diseases is provided. Understanding of the mechanisms that augment innate immune responsiveness in neonates may facilitate the development of improved vaccination protocols that can protect against pathogens and organ damage.</p>
</abstract>
<kwd-group>
<kwd>neonates</kwd>
<kwd>innate immunity</kwd>
<kwd>infections</kwd>
<kwd>sepsis</kwd>
<kwd>neurodevelopment</kwd>
<kwd>brain injury</kwd>
</kwd-group>
<counts>
<fig-count count="2"></fig-count>
<table-count count="0"></table-count>
<equation-count count="0"></equation-count>
<ref-count count="107"></ref-count>
<page-count count="10"></page-count>
<word-count count="7448"></word-count>
</counts>
</article-meta>
</front>
<body>
<sec id="s1" sec-type="intro">
<title>Introduction</title>
<p>During early life, newborns encounter a plethora of antigenic challenges derived from pathogens, commensals, and innocuous environmental antigens (<xref ref-type="bibr" rid="B1">1</xref>). In the face of an inexperienced adaptive immunity, innate immunity is critical for the survival of neonates. Still, deficits in innate immune cell functions, due to cell-intrinsic hyporesponsiveness concomitant with enhanced activation of immunosuppressive, tissue-protective mechanisms, render neonates vulnerable to infections, sepsis, brain damage and neurodevelopmental disorders (<xref ref-type="bibr" rid="B2">2</xref>–<xref ref-type="bibr" rid="B5">5</xref>). Rapidly-changing environmental and microbial exposures in the post-natal period, along with epigenetic reprogramming and innate immune memory, have also a major impact on neonatal immune responses (<xref ref-type="bibr" rid="B6">6</xref>). Despite significant scientific progress, the precise cellular and molecular mechanisms underlying defective neonatal innate immunity remain incompletely defined.</p>
<p>In this review, we present the most recent advances in the characterization of the phenotype and functions of neonatal innate immune cells, outlining the disparities with adult responses. Given that there is limited space to delve into the extensive series of animal studies, we focus on reports on human cells. In addition, we provide an overview of the effects of the microbiome, the metabolome, and epigenetics on the regulation of neonatal innate immunity. The immunological mechanisms underlying infections, brain injury, and neurodevelopmental disorders are also presented. Finally, we discuss future research directions that may boost neonatal host defense through targeting innate immune responses.</p>
</sec>
<sec id="s2">
<title>Innate Immune Responses in Neonates</title>
<sec>
<title>Dendritic Cells</title>
<p>Human dendritic cells (DCs) mainly consist of two developmentally-distinct lineages; conventional (cDCs) that induce T cell activation and differentiation, and plasmacytoid DCs (pDCs), which produce type I interferons and mediate anti-viral responses (<xref ref-type="bibr" rid="B7">7</xref>). Neonatal cDCs are decreased in the peripheral blood and upon pathogen encounter [i.e., lipopolysaccharide (LPS) stimulation], secrete low levels of IL-12, leading to impaired T helper type (Th1) cell polarization (<xref ref-type="bibr" rid="B8">8</xref>). Decreased IL-12 synthesis by neonatal cDCs is associated with impaired chromatin remodeling in the gene promoter (<xref ref-type="bibr" rid="B9">9</xref>). Notably, neonatal cDCs secrete high levels of Th2 cell-associated cytokines, such as IL-4 and IL-13, which along with the anti-inflammatory cytokine IL-10, retain cDCs in an immature state (<xref ref-type="bibr" rid="B10">10</xref>). The expression of human leukocyte antigen (HLA)-DR and costimulatory molecules, such as CD40, CD80, and CD86, are also decreased in neonatal cDCs, reducing their antigen-presenting and T cell stimulatory functions (<xref ref-type="bibr" rid="B11">11</xref>). Defective production of IFN-β and IFN-inducible chemokine genes, including CXCL9, CXCL10, and CXCL11, by neonatal DCs is considered to result from decreased expression of IRF-3-dependent genes (<xref ref-type="bibr" rid="B9">9</xref>). Nevertheless, recent studies using cytometry by time of flight-assisted immunophenotypic analyses have shown that fetal and adult cDCs have similar expression of pattern recognition receptors (PRRs) and secrete equal amounts of GM-CSF, IL-6, CXCL8, and CCL4 following stimulation with several toll-like receptor (TLR) agonists [i.e., CL075, cytosine-phosphate-guanosine (CpG) oligodeoxynucleotides, polyinosinic-polycytidylic acid (PI:C), peptidoglycan (PGN)] <italic>ex vivo</italic> (<xref ref-type="bibr" rid="B12">12</xref>). These findings suggest that endogenous immunosuppressive and/or other factors may restrain neonatal cDC maturation and T cell stimulatory functions <italic>in vivo</italic>. Upon stimulation with TLR7 ligands, cytomegalovirus, herpes simplex virus-1 (HSV-1), or CpG, pDCs, also release decreased amounts of IFN-α, even though TLRs, HLA-DR, and costimulatory molecules are expressed at similar levels to their adult counterparts (<xref ref-type="bibr" rid="B13">13</xref>, <xref ref-type="bibr" rid="B14">14</xref>).</p>
</sec>
<sec>
<title>Monocytes and Macrophages</title>
<p>Monocytes play a key role in pathogen recognition and eradication through their phagocytic, antigen-presenting and cytokine-secreting abilities. Neonatal monocytes express decreased levels of HLA-DR and CD80, leading to impaired presentation of antigens, including pathogen-derived molecules (<xref ref-type="bibr" rid="B15">15</xref>). They are also characterized by reduced expression of membrane attack complex-1 and L-selectin, leading to decreased adhesion and infiltration to inflamed tissues (<xref ref-type="bibr" rid="B16">16</xref>). Interestingly, although stimulation with LPS enhances TLR4 expression, along with TNF-α, IL-6, and IL-10 secretion by neonatal macrophages, downstream TLR4 signaling pathways are impaired, as evidenced by reduced phosphorylation of NF-κβ-p65 and p38, and this may account for the overall decreased cytokine responses as compared to adult cells (<xref ref-type="bibr" rid="B17">17</xref>, <xref ref-type="bibr" rid="B18">18</xref>). Neonatal monocytes also exhibit impaired activation of the nucleotide-binding domain and leucine-rich repeat containing protein 3 (NLRP3) inflammasome. In fact, following NLRP3 stimulation, low levels of caspase-1 lead to decreased pyroptosis and reduced secretion of active IL-1β (<xref ref-type="bibr" rid="B19">19</xref>). In contrast, neonatal monocytes express higher levels of the anti-apoptotic protein B-cell lymphoma 2 (Bcl-2), that prevents physiological termination of their responses and can exacerbate inflammatory processes (<xref ref-type="bibr" rid="B20">20</xref>). Additional studies have shown that macrophages produce high levels of migration inhibitory factor which enhances mitogen-activated protein kinase (MAPK) activation, and during sepsis, may lead to excessive cytokine release (<xref ref-type="bibr" rid="B14">14</xref>).</p>
<p>Compared to their adult counterparts, neonatal macrophages have increased cytoplasmic vacuolization and reduced expression of lipid residues, CD11b, CD14, and F4/80 (<xref ref-type="bibr" rid="B21">21</xref>). Still, upon pathogen encounter, they produce copious amounts of IL-6 and CCL2/3/4 (<xref ref-type="bibr" rid="B21">21</xref>). Given the inhibitory effects of IL-6 on neutrophil responses, the increased IL-6/TNF-α ratio in neonatal peripheral blood as described above, may account for the reduced neutrophilic migration to inflammatory tissue sites (<xref ref-type="bibr" rid="B22">22</xref>). Phagocytic responses of neonatal macrophages are similar to those of adults (<xref ref-type="bibr" rid="B23">23</xref>).</p>
<p>Overall, these studies highlight impaired antigen-presenting functions, cytokine secretion and T cell stimulatory abilities of neonatal DCs and monocytes/macrophages upon pathogen encounter, a phenomenon that renders neonates particularly vulnerable to infections (<xref ref-type="fig" rid="F1">Figure 1</xref>). Still, it remains elusive whether the aforementioned defects are due to inherent immaturity of the neonatal innate immune system, the activation of endogenous immunosuppressive mechanisms or both, and future studies should further explore these clinically-relevant questions.</p>
<fig id="F1" position="float">
<label>Figure 1</label>
<caption>
<p>Innate immune responses in neonates. The quantitative and functional characteristics of neonatal innate immune responses are depicted and compared to those of adults. These features of innate immune cells render newborns vulnerable to severe infections and organ damage.</p>
</caption>
<graphic xlink:href="fped-08-00005-g0001"></graphic>
</fig>
</sec>
<sec>
<title>Granulocytes</title>
<p>Neutrophils provide the first line of defense against pathogens through phagocytosis, release of toxic substances and generation of neutrophil extracellular traps (NETs). Neonatal neutrophils exhibit impaired rolling and adhesion capabilities, resulting from decreased expression of L-selectin, CD11b/CD18, and P-selectin glycoprotein ligand-1 (<xref ref-type="bibr" rid="B24">24</xref>, <xref ref-type="bibr" rid="B25">25</xref>). They are also characterized by decreased calcium influx and intracellular calcium mobilization that affect actin polymerization, the microfilamentous cytoskeleton and chemotactic responses (<xref ref-type="bibr" rid="B26">26</xref>, <xref ref-type="bibr" rid="B27">27</xref>). Moreover, decreased complement receptor 3 and nicotinamide adenine dinucleotide phosphate expression further reduce transendothelial migration and correlate with deficiency in opsonization and phagocytosis (<xref ref-type="bibr" rid="B25">25</xref>, <xref ref-type="bibr" rid="B28">28</xref>, <xref ref-type="bibr" rid="B29">29</xref>). NETosis is impaired compared to adult cells and lactoferrin, myeloperoxidase granule proteins and azurophilic protein are reduced in neonatal neutrophil extracts [(<xref ref-type="bibr" rid="B29">29</xref>); <xref ref-type="fig" rid="F1">Figure 1</xref>]. Global proteomics analyses of cord and adult blood neutrophils validated the aforementioned findings showing downregulation of key proteins involved in proteasome, lysosome, and phagosome functions as well as in transendothelial migration (<xref ref-type="bibr" rid="B29">29</xref>). There is limited information pertinent to responses of other granulocytes. Animal studies have shown that neonatal basophils, through enhanced IL-4 production, trigger Th2-polarized responses and downregulate IL-12 release by cDCs (<xref ref-type="bibr" rid="B30">30</xref>).</p>
</sec>
<sec>
<title>Natural Killer (NK) Cells</title>
<p>NK cells protect against pathogens through cytokine release and killing of infected cells. Expression of a complex repertoire of activating (CD94/NKG2C, killer immunoglobulin-like 1 receptor) and inhibitory receptors (CD94/NKG2A) enables NKs to sense infected and/or transformed cells (<xref ref-type="bibr" rid="B31">31</xref>, <xref ref-type="bibr" rid="B32">32</xref>). NK numbers are increased during gestation, reaching their peak at birth, after which they decline reaching adult levels (<xref ref-type="bibr" rid="B31">31</xref>, <xref ref-type="bibr" rid="B32">32</xref>). Inhibitory receptors are increased in neonatal NKs, endowing them with a cytokine-secreting rather than a cytotoxic profile. Nevertheless, the inhibitory receptor leukocyte immunoglobulin-like receptor-1, is reduced in newborn NKs (<xref ref-type="bibr" rid="B32">32</xref>). Cord blood NKs exhibit decreased degranulation abilities, as evidenced by reduced CD107c and lower production of perforin and granzymes, which result in poor cytotoxicity upon encounter of infected cells (<xref ref-type="bibr" rid="B31">31</xref>). In contrast, antibody-dependent cell-mediated cytotoxicity (ADCC) is not different to adults, as evidenced by equivalent Fcγ-RIII/CD16 levels [(<xref ref-type="bibr" rid="B32">32</xref>); <xref ref-type="fig" rid="F1">Figure 1</xref>]. IFN-γ release is dampened in cord blood NKs mainly due to low IL-12 secretion by cDCs (<xref ref-type="bibr" rid="B33">33</xref>). NK adhesion is also impaired due to reduced CD62L/L-selectin and CD54/ICAM-1, whereas β2-integrin levels are similar to adult counterparts (<xref ref-type="bibr" rid="B34">34</xref>).</p>
</sec>
<sec>
<title>Innate Lymphoid Cells (ILCs)</title>
<p>Innate Lymphoid Cells (ILCs) are characterized by the release of Th cell-associated cytokines and the absence of antigen-specific receptors. ILCs are classified into three subgroups (ILC1, ILC2, ILC3), based on their cytokine and transcription factor profile and represent essential drivers of early host responses during infection and injury (<xref ref-type="bibr" rid="B35">35</xref>). ILCs presence and functionality is increased during infancy, wherein ILCs contribute to lymphoid tissue formation and gut homeostasis by regulating microbiome installation and metabolic processes (<xref ref-type="bibr" rid="B36">36</xref>, <xref ref-type="bibr" rid="B37">37</xref>). During intra-amniotic infection, ILCs migrate to the amniotic fluid and participate in tissue repair (<xref ref-type="bibr" rid="B36">36</xref>). Interestingly, neonatal mouse ILC3s inhibit lymphopenia-induced proliferation (LIP), a process that leads to aberrant T cell activation, tissue destruction and loss of T-cell receptor diversity (<xref ref-type="bibr" rid="B37">37</xref>). This creates a diverse repertoire of naive T cells that is essential for T cell homeostasis and induction of immunological tolerance (<xref ref-type="fig" rid="F1">Figure 1</xref>). The human infant oral epithelium exhibits a predominance of ILC2s that produce Th2 cytokines, important for defense against extracellular bacteria and parasites (<xref ref-type="bibr" rid="B38">38</xref>).</p>
</sec>
</sec>
<sec id="s3">
<title>Factors Influencing Neonatal Innate Immunity</title>
<sec>
<title>Epigenetics</title>
<p>Epigenetic modifications, including acetylation, methylation, ubiquitination, phosphorylation and sumoylation on histones, and/or DNA, as well as, microRNA-mediated regulation of translation have a major impact on innate immunity. Studies conducted during the post-natal period have shown a decrease of the histone mark H3K4me1 in monocytes, concomitant with a gradual increase of the H3K4me3 mark, mostly at promoter regions (<xref ref-type="bibr" rid="B39">39</xref>). The decreased H3K4me3 abundance early-on at pro-inflammatory genes, including CCR2, IL-1β, and TNF-α, is associated with reduced expression (<xref ref-type="bibr" rid="B39">39</xref>). In fact, the increased ratio H3K4me1/H3K4me3 may also underlie the impaired antigen-presenting functions of neonatal monocytes (<xref ref-type="bibr" rid="B39">39</xref>). Interestingly, low levels of H3K4me3 at genes encoding aerobic glycolysis pathways are also observed in neonatal monocytes (<xref ref-type="bibr" rid="B40">40</xref>). Considering that a metabolic shift from oxidative phosphorylation to glycolysis and/or lipid metabolism is pivotal for the induction of immune response genes in macrophages, these observations have important ramifications for the increased susceptibility of neonates to infections. Another study showed that monocytes derived from newborns born to obese mothers display reduced LPS responsiveness, associated with altered cytokine promoter methylation (<xref ref-type="bibr" rid="B41">41</xref>). In contrast, CpG methylation patterns in cord blood NKs did not differ from their adult counterparts (<xref ref-type="bibr" rid="B42">42</xref>). Pertinent to microRNAs, cord blood monocytes have increased miR146a that represses TLR4 signaling and pro-inflammatory cytokine secretion (<xref ref-type="bibr" rid="B43">43</xref>).</p>
</sec>
<sec>
<title>Microbiome</title>
<p>The microbiome plays a catalytic role in the maturation of neonatal immune responses. In fact, only during juvenility, wherein the microbiome shifts to the adult composition, the establishment of a fully-operating immune system occurs (<xref ref-type="bibr" rid="B44">44</xref>). Microbial colonization was considered to occur during and following delivery (<xref ref-type="bibr" rid="B44">44</xref>). However, bacterial DNA was recently detected in the placental tissue and amniotic fluid, suggesting that initiation of microbiome colonization occurs prenatally (<xref ref-type="bibr" rid="B41">41</xref>, <xref ref-type="bibr" rid="B45">45</xref>). Several prenatal and perinatal factors, including the mode of delivery, antibiotics consumption and diet, shape the microbial community, and consequently, the maturation of neonatal immunity. The neonatal microbiome exhibits lower diversity, compared to adults (<xref ref-type="bibr" rid="B44">44</xref>). Microbiota mainly consisting of <italic>Bacteroidetes, Firmicutes, Proteobacteria, Actinobacteria, Enterobacteriaceae</italic>, and <italic>Bifidobacterium</italic> are essential for the generation of an anaerobic environment in the neonatal intestine and compete with pathogens for nutrients, pH, adhesion sites and production of metabolites (<xref ref-type="bibr" rid="B44">44</xref>).</p>
<p>Experimental studies using germ-free mice demonstrated that the microbiome affects macrophage development and polarization, granulocyte numbers and haematopoiesis during early life (<xref ref-type="bibr" rid="B46">46</xref>, <xref ref-type="bibr" rid="B47">47</xref>). For example, the presence of <italic>Lactobacillus</italic> in the maternal vagina correlates with IL-12 levels in neonatal cord blood, while an inverse correlation exists between <italic>Bacteroides fragilis</italic> and LPS-induced CCL4 and IL-6 production by mononuclear cells (<xref ref-type="bibr" rid="B48">48</xref>). Decreased presence of the <italic>Bacteroidetes</italic> phylum is also associated with lower plasma CXCL10 and CXCL11 levels in infants (<xref ref-type="bibr" rid="B48">48</xref>).</p>
<p>Collectively, the aforementioned studies suggest that epigenetic alterations and the microbiome composition greatly affect neonatal innate immune responses; however, the precise immunological and molecular mechanisms involved remained incompletely explored. Further animal studies and <italic>ex vivo</italic> analyses of human clinical samples are needed to delineate these intricate interactions and understand how they can be harnessed for the enhancement of protective immunity in neonates.</p>
</sec>
<sec>
<title>Metabolome</title>
<p>The past years, there is an increasing interest in the analysis of the metabolome of biological fluids, including the amniotic fluid, the cord and the peripheral blood, the saliva, and the urine in newborns (<xref ref-type="bibr" rid="B49">49</xref>). Neonates exhibit a constantly-changing metabolomic profile that correlates with alterations in their environment, diet and the microbiome. For example, glycine is an essential amino acid that participates in glutathione synthesis and protects against oxidative stress, promotes the formation of purines, hemes, collagen and elastin, and enhances neurotransmission (<xref ref-type="bibr" rid="B49">49</xref>). Glycine is increased in neonates, and especially in preterms and/or newborns with intrauterine growth restriction, compared to adults, a process possibly associated with their enhanced metabolic demands (<xref ref-type="bibr" rid="B50">50</xref>). Choline, a precursor of lipoproteins and phospholipids involved in neurotransmission, is increased in neonates with cerebral damage and sepsis and contributes to metabolic imbalance (<xref ref-type="bibr" rid="B51">51</xref>–<xref ref-type="bibr" rid="B53">53</xref>). In contrast, reduced choline levels are detected in preterm and low birth-weight neonates and associated with decreased survival and impaired energy demands (<xref ref-type="bibr" rid="B54">54</xref>).</p>
<p>The interdependency of the microbiome, diet and the metabolome is exemplified by the colonization of the neonatal intestine early-on during development by the <italic>Bifidobacterium</italic> species that plays a key role in the generation of oligosaccharides through breastfeeding (<xref ref-type="bibr" rid="B55">55</xref>). Moreover, recent studies have shown that the metabolome is significantly altered in germ-free mice (<xref ref-type="bibr" rid="B56">56</xref>), while the administration of probiotics and prebiotics affect metabolite composition (<xref ref-type="bibr" rid="B57">57</xref>, <xref ref-type="bibr" rid="B58">58</xref>). The levels of gluconate, a fundamental metabolite provided through glucose oxidation or products of <italic>Enterococcus faecalis</italic> and <italic>Escherichia coli</italic>, are enhanced in preterm neonates with necrotizing enterocolitis (NEC), which are also characterized by an altered microbiome composition (<xref ref-type="bibr" rid="B59">59</xref>, <xref ref-type="bibr" rid="B60">60</xref>). Considering that the metabolomics field is still in its infancy, further studies are required to delineate its precise role in orchestrating innate immune responses in neonates. Still, the generation of a metabolome “map” is expected to significantly enhance the identification of new disease biomarkers, provide crucial opportunities for early diagnosis and facilitate the understanding of unknown aspects of the neonatal physiology.</p>
</sec>
</sec>
<sec id="s4">
<title>Dysregulation of Neonatal Innate Immunity</title>
<sec>
<title>Infections</title>
<p>Dysregulated innate immune responses render newborns susceptible to severe infections. Neonatal sepsis occurs predominantly in response to respiratory tract infections and meningitis, and represents a major cause of morbidity and mortality in the neonatal period, especially in very low birth-weight preterm infants (<xref ref-type="bibr" rid="B61">61</xref>). <italic>In utero</italic> infection is a significant risk factor for the development of early onset (EOS) sepsis (<xref ref-type="bibr" rid="B61">61</xref>, <xref ref-type="bibr" rid="B62">62</xref>). EOS and late-onset sepsis (LOS) are characterized by differences in the time of infection and the way of transmission (<xref ref-type="bibr" rid="B61">61</xref>, <xref ref-type="bibr" rid="B62">62</xref>). <italic>Group B Streptococci</italic> and <italic>Escherichia coli</italic> are predominantly involved in EOS, while <italic>Coagulase negative Staphylococci</italic> is observed in LOS (<xref ref-type="bibr" rid="B63">63</xref>). Viral infections, including HSV, enteroviruses, and parechoviruses, are also implicated in EOS (<xref ref-type="bibr" rid="B61">61</xref>).</p>
<p>Accumulating evidence illuminates critical defects of neonatal innate immunity during sepsis. Septic neonates present deficiencies in the recognition of pathogen products, including LPS, and in TNF-α, IFN-γ, IL-12 release that stem on TLR (especially TLR4) defects and reduced intracellular signaling by myeloid differentiation primary response protein 88 and MAPK p38 [(<xref ref-type="bibr" rid="B43">43</xref>); <xref ref-type="fig" rid="F2">Figure 2</xref> and <xref ref-type="supplementary-material" rid="SM1">Supplemental Table 1</xref>]. Moreover, preterms exhibit decreased LPS-induced TNF-α release, while cDCs secrete reduced amounts of IL-12, compared to non-septic preterms (<xref ref-type="bibr" rid="B5">5</xref>). In contrast, circulating IL-10 concentrations are elevated during EOS and LOS, enhancing an immunosuppressive milieu and limiting the ability of innate immune cells to eliminate pathogens (<xref ref-type="bibr" rid="B64">64</xref>). High levels of plasma adenosine trigger intracellular accumulation of immunosuppressive cAMP and further inhibit LPS-induced cytokine production (<xref ref-type="bibr" rid="B65">65</xref>). C9 levels are approximately 50% of their adult counterparts and linked to deficient opsonization and bacterial killing (<xref ref-type="bibr" rid="B66">66</xref>). Reduced levels of opsonins, mannose-binding lectin, bactericidal permeability-increasing protein and human neutrophil peptide also correlate with a high incidence of neonatal sepsis (<xref ref-type="bibr" rid="B5">5</xref>). Pertinent to cellular responses, macrophages produce decreased levels of reactive nitrogen intermediates (<xref ref-type="bibr" rid="B67">67</xref>), while monocytes express lower HLA-DR (<xref ref-type="bibr" rid="B11">11</xref>). Functional and quantitative deficiencies of neonatal neutrophils also increase the risk of development and dissemination of bacterial infections (<xref ref-type="bibr" rid="B65">65</xref>). For example, deficient NET formation and NET-mediated killing is observed during sepsis (<xref ref-type="bibr" rid="B68">68</xref>). Moreover, decreased circulating levels of TNF-α, IFN-γ, IFN-α, and IL-12 during neonatal sepsis impair NK cell-mediated cytotoxicity [(<xref ref-type="bibr" rid="B62">62</xref>, <xref ref-type="bibr" rid="B69">69</xref>); <xref ref-type="fig" rid="F2">Figure 2</xref> and <xref ref-type="supplementary-material" rid="SM1">Supplemental Table 1</xref>].</p>
<fig id="F2" position="float">
<label>Figure 2</label>
<caption>
<p>Dysregulated neuro-immune communication underlies the pathology of infections and CNS disorders in neonates. Infections, such as chorioamnionitis, dermatitis, meningitis, necrotizing enterocolitis, and respiratory infections, can lead to systemic inflammation and severe sepsis in newborns. Pathogen associated molecular patterns (PAMPs), generated during infections, are recognized via PRRs by innate immune cells and this induces cell activation and the production of pro-inflammatory mediators in the periphery and the CNS. On the other hand, maternal infections during pregnancy and/or EOS, and intrapartum asphyxia can induce brain injury and HIE, respectively, and further activate innate immune responses. Dysregulated neuro-immune communications underlie the pathogenesis of systemic infections and brain damage in neonates and may lead to neurodevelopmental and neuropsychiatric disorders.</p>
</caption>
<graphic xlink:href="fped-08-00005-g0002"></graphic>
</fig>
<p>Strikingly, neonates can also exhibit exaggerated innate immune responses that may lead to severe organ damage. Indeed, systemic inflammation during neonatal infections is closely linked to brain injury and neurological impairments (<xref ref-type="bibr" rid="B70">70</xref>, <xref ref-type="bibr" rid="B71">71</xref>). The levels of IL-6 (<xref ref-type="bibr" rid="B72">72</xref>), CXCL8 (<xref ref-type="bibr" rid="B73">73</xref>), and IFN-γ (<xref ref-type="bibr" rid="B72">72</xref>) are elevated in the circulation of septic neonates and correlate with disease severity, whereas TNF-α and IL-1β production is more variable (<xref ref-type="bibr" rid="B74">74</xref>, <xref ref-type="bibr" rid="B75">75</xref>). In chorioamnionitis, occurring as a result of intra-uterine infection and/or sterile inflammation, invasion of microorganisms or release of stress factors (i.e., danger signals and alarmins) in the amniotic cavity augments IL-1β, IL-6,TNF-α, CXCL8, and CXCL6 secretion and activates NLRP3 signaling (<xref ref-type="bibr" rid="B76">76</xref>, <xref ref-type="bibr" rid="B77">77</xref>). This enhanced chemotactic gradient stimulates neutrophilic infiltration from the decidua into the chorioamniotic membranes and may lead to necrotizing chorioamnionitis, premature rupture of membranes, NEC, bronchopulmonary dysplasia, and periventricular leukomalacia [(<xref ref-type="bibr" rid="B78">78</xref>); <xref ref-type="fig" rid="F2">Figure 2</xref> and <xref ref-type="supplementary-material" rid="SM1">Supplemental Table 1</xref>]. Aberrant macrophage activation is also implicated in this exaggerated response (<xref ref-type="bibr" rid="B77">77</xref>). In the context of preterm labor induced by chorioamnionitis, fetal inflammatory response syndrome, severe dermatitis, and pneumonitis may be developed (<xref ref-type="bibr" rid="B78">78</xref>). In contrast, chorioamnionitis is associated with a reduced risk of LOS, possibly due to the establishment of innate immune memory that enhances protective immunity upon subsequent pathogen exposure (<xref ref-type="bibr" rid="B78">78</xref>).</p>
</sec>
<sec>
<title>Neurodevelopmental Disorders</title>
<p>Several molecules involved in innate immunity, including cytokines, the complement cascade and adhesion molecules, are expressed in the healthy brain wherein they play essential roles in neurogenesis, migration, differentiation, synapse formation, and plasticity (<xref ref-type="bibr" rid="B79">79</xref>, <xref ref-type="bibr" rid="B80">80</xref>). Still, dysregulated expression of these factors during early life can have deleterious consequences on brain development and function.</p>
<p>Intrapartum asphyxia causes hypoxia-ischemia (HI) which induces long-term neurological disorders, including cerebral palsy, visual impairment, seizures, epilepsy, mental retardation, and learning disabilities (<xref ref-type="bibr" rid="B81">81</xref>). Neonatal hypoxic-ischemic encephalopathy (HIE) is characterized by extensive neuronal cell death (<xref ref-type="bibr" rid="B81">81</xref>). Danger signals derived from dead and/or apoptotic neurons, including IL-33, high-mobility group protein B1 and ATP, are recognized by microglia, astrocytes and perivascular macrophages and induce their activation and release of pro-inflammatory cytokines, chemokines, nitric oxide synthase, ROS and excitatory amino acids (<xref ref-type="bibr" rid="B82">82</xref>). Furthermore, TNF-α, IL-6, IL-1β, and IL-12 release increase the blood-brain barrier permeability, augmenting the infiltration of DCs, and monocytes/macrophages into the brain (<xref ref-type="bibr" rid="B2">2</xref>). IL-6R, IL-1βR, and IL-18R activation in brain endothelial cells also increases production of TNF-α, activator protein 1 and prostaglandins (<xref ref-type="bibr" rid="B82">82</xref>). Altogether, these factors alter neuronal excitability and neurotransmitter function as they induce an imbalance in gamma-aminobutyric acid and glutamate, promoting long-term defects on synapse formation and neurogenesis (<xref ref-type="bibr" rid="B73">73</xref>, <xref ref-type="bibr" rid="B74">74</xref>, <xref ref-type="bibr" rid="B77">77</xref>). Newborns with HIE have elevated expression of TNF-α and IL-1β in the serum and cerebrospinal fluid (CSF), which correlate with brain injury severity (<xref ref-type="bibr" rid="B83">83</xref>). CXCL8 and IL-6 are also increased in the blood and CSF during perinatal asphyxia and correlate with HIE severity and neurological outcome (<xref ref-type="bibr" rid="B83">83</xref>–<xref ref-type="bibr" rid="B85">85</xref>). IL-10 is higher in the serum of asphyxiated neonates, while enhanced neutrophilic infiltration during the first 96 h is associated with poor neurodevelopmental outcomes [(<xref ref-type="bibr" rid="B86">86</xref>, <xref ref-type="bibr" rid="B87">87</xref>); <xref ref-type="fig" rid="F2">Figure 2</xref> and <xref ref-type="supplementary-material" rid="SM1">Supplemental Table 1</xref>].</p>
<p>Autism spectrum disorders (ASD), Alzheimer's disease, major depression and schizophrenia, are considered as closely linked to three interrelated mechanisms; (a) dysregulated neuro-immune communication, (b) dysbiosis of the gut microbiome, and (c) early-life infections (<xref ref-type="bibr" rid="B3">3</xref>, <xref ref-type="bibr" rid="B4">4</xref>, <xref ref-type="bibr" rid="B88">88</xref>, <xref ref-type="bibr" rid="B89">89</xref>). Animal studies have demonstrated that maternal viral infections during gestation, along with aberrant activation of innate immunity, have a long-lasting impact on offspring brain development and anxiety behavior, often in a sex-dependent manner, due to the activation of the hypothalamic-pituitary-adrenal axis (<xref ref-type="bibr" rid="B90">90</xref>). Children with ASD exhibit impaired NK cytotoxicity (<xref ref-type="bibr" rid="B91">91</xref>) and elevated production of TNF-α, IL-2, CXCL8, and IL-6 in the CSF (<xref ref-type="bibr" rid="B92">92</xref>). CCL2 and CCL5 are also increased in the brain of autistic children and associated with microglial activation and behavioral changes (<xref ref-type="bibr" rid="B92">92</xref>, <xref ref-type="bibr" rid="B93">93</xref>). Increased IL-1β and IL-4 are associated with severe ASD (<xref ref-type="bibr" rid="B94">94</xref>), while IL-10 and TGF-β are decreased in the circulation (<xref ref-type="bibr" rid="B95">95</xref>). In contrast, neuroprotective factors, including brain-derived neurotrophic factor and Bcl-2, are decreased in ASD children [(<xref ref-type="bibr" rid="B96">96</xref>, <xref ref-type="bibr" rid="B97">97</xref>); <xref ref-type="fig" rid="F2">Figure 2</xref> and <xref ref-type="supplementary-material" rid="SM1">Supplemental Table 1</xref>]. Interestingly, newborns with sepsis exhibit an increased risk of brain injury compared to those with chorioamnionitis, suggesting that similar to its protective effects on subsequent infections, chorioamnionitis preconditions the developing brain against subsequent injury induced by HI (<xref ref-type="bibr" rid="B98">98</xref>).</p>
</sec>
</sec>
<sec id="s5" sec-type="discussion">
<title>Discussion</title>
<p>It is becoming increasingly clear that the development of immune responses in neonates is compromised not only as a result of immaturity but also as an attempt to maintain tolerance to innocuous and commensal antigens and prevent tissue damage. Still, once neonatal immune responses are activated, their magnitude is often such that they can cause severe immune pathology and morbidity, especially during infections and HI (<xref ref-type="fig" rid="F2">Figure 2</xref> and <xref ref-type="supplementary-material" rid="SM1">Supplemental Table 1</xref>). Hence, the provision of broadly-active innate immune stimuli during early life may protect against the detrimental consequences of uncontrolled inflammation, concomitant with the establishment of protective immunity. Vaccine-induced immune responses in neonates are impaired in terms of quantity and quality and multiple boosters are required to promote immunological memory (<xref ref-type="bibr" rid="B99">99</xref>, <xref ref-type="bibr" rid="B100">100</xref>). On the other hand, vaccination with Bacille Calmette-Guerin (BCG) decreases neonatal mortality caused by infections by promoting heterologous lymphocyte activation against antigenically diverse and unrelated pathogens and through enhancing innate immune memory (<xref ref-type="bibr" rid="B101">101</xref>). Still, apart from BCG, hepatitis B and oral poliovirus, there are no other vaccines given after birth, highlighting a critical unmet need for this vulnerable young population (<xref ref-type="bibr" rid="B99">99</xref>, <xref ref-type="bibr" rid="B102">102</xref>). It becomes evident that future studies should focus on enhancing vaccine effectiveness through stimulation of innate immune responses, for example, via administration of synthetic TLR8 agonists, including imidazoquinolines and single-stranded RNAs (<xref ref-type="bibr" rid="B99">99</xref>, <xref ref-type="bibr" rid="B100">100</xref>). Alternatively, targeting TLR-independent pathways and bypassing immunosuppressive networks can also boost protective immunity without compromising crucial homeostatic functions.</p>
<p>Intricate interactions between the microbiome and the nervous and the immune systems affect neonatal responses during infections and brain injury. As such, alterations in the microbial composition, for example through dietary supplementation, may modulate key pathways of neuroimmune communication and enhance regulatory mechanisms that prevent neuronal damage. Interventions, including corticosteroids, melatonin, erythropoietin, anti-TNF-α antibodies, and IL-1rα administration, in clinical use for other diseases, may be also utilized for the control of neurological disorders in susceptible neonates (<xref ref-type="bibr" rid="B103">103</xref>–<xref ref-type="bibr" rid="B107">107</xref>). Finally, advances in systems-based approaches, including high-resolution genomic, proteomic, and metabolomic technologies are expected to provide new insight into the mechanisms underlying gut, brain and immune system interactions, and guide the development of more accurate diagnostic tests and therapeutic interventions.</p>
</sec>
<sec id="s6">
<title>Author Contributions</title>
<p>GT and PN searched the literature and wrote the manuscript. GT designed the figures. GX contributed to critical revision of the article, suggested additional references, and wrote the manuscript. All authors read and approved the final manuscript.</p>
<sec>
<title>Conflict of Interest</title>
<p>The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.</p>
</sec>
</sec>
</body>
<back>
<fn-group>
<fn fn-type="financial-disclosure">
<p><bold>Funding.</bold> GX was supported by an Academia-Industry Co-Operation Program grant (09-12-1074), a Research Excellence Grant (# 5035) funded by the General Secretariat for Research and Technology (GSRT), and by a Fondation Santé Research Grant in the Biomedical Sciences.</p>
</fn>
</fn-group>
<sec id="s7" sec-type="supplementary-material">
<title>Supplementary Material</title>
<p>The Supplementary Material for this article can be found online at: <ext-link ext-link-type="uri" xlink:href="https://www.frontiersin.org/articles/10.3389/fped.2020.00005/full#supplementary-material">https://www.frontiersin.org/articles/10.3389/fped.2020.00005/full#supplementary-material</ext-link></p>
<supplementary-material content-type="local-data" id="SM1">
<media xlink:href="Data_Sheet_1.PDF">
<caption>
<p>Click here for additional data file.</p>
</caption>
</media>
</supplementary-material>
</sec>
<ref-list>
<title>References</title>
<ref id="B1">
<label>1.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Swanson</surname><given-names>JR</given-names></name><name><surname>Sinkin</surname><given-names>RA</given-names></name></person-group>. <article-title>Transition from fetus to newborn</article-title>. <source/>Pediatr Clin North Am. (<year>2015</year>) <volume>62</volume>:<fpage>329</fpage>–<lpage>43</lpage>. <pub-id pub-id-type="doi">10.1016/j.pcl.2014.11.002</pub-id><pub-id pub-id-type="pmid">25836701</pub-id></mixed-citation>
</ref>
<ref id="B2">
<label>2.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>McAdams</surname><given-names>RM</given-names></name><name><surname>Juul</surname><given-names>SE</given-names></name></person-group>. <article-title>The role of cytokines and inflammatory cells in perinatal brain injury</article-title>. <source/>Neurol Res Int. (<year>2012</year>) <volume>2012</volume>:<fpage>561494</fpage>. <pub-id pub-id-type="doi">10.1155/2012/561494</pub-id><pub-id pub-id-type="pmid">22530124</pub-id></mixed-citation>
</ref>
<ref id="B3">
<label>3.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Milgrom</surname><given-names>J</given-names></name><name><surname>Gemmill</surname><given-names>AW</given-names></name><name><surname>Bilszta</surname><given-names>JL</given-names></name><name><surname>Hayes</surname><given-names>B</given-names></name><name><surname>Barnett</surname><given-names>B</given-names></name><name><surname>Brooks</surname><given-names>J</given-names></name><etal></etal></person-group>. <article-title>Antenatal risk factors for postnatal depression: a large prospective study</article-title>. <source/>J Affect Disord. (<year>2008</year>) <volume>108</volume>:<fpage>147</fpage>–<lpage>57</lpage>. <pub-id pub-id-type="doi">10.1016/j.jad.2007.10.014</pub-id><pub-id pub-id-type="pmid">18067974</pub-id></mixed-citation>
</ref>
<ref id="B4">
<label>4.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Borenstein</surname><given-names>AR</given-names></name><name><surname>Copenhaver</surname><given-names>CI</given-names></name><name><surname>Mortimer</surname><given-names>JA</given-names></name></person-group>. <article-title>Early-life risk factors for Alzheimer disease</article-title>. <source/>Alzheimer Dis Assoc Disord. (<year>2006</year>) <volume>20</volume>:<fpage>63</fpage>–<lpage>72</lpage>. <pub-id pub-id-type="doi">10.1097/01.wad.0000201854.62116.d7</pub-id><pub-id pub-id-type="pmid">16493239</pub-id></mixed-citation>
</ref>
<ref id="B5">
<label>5.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wynn</surname><given-names>JL</given-names></name><name><surname>Levy</surname><given-names>O</given-names></name></person-group>. <article-title>Role of innate host defenses in susceptibility to early-onset neonatal sepsis</article-title>. <source/>Clin Perinatol. (<year>2010</year>) <volume>37</volume>:<fpage>307</fpage>–<lpage>37</lpage>. <pub-id pub-id-type="doi">10.1016/j.clp.2010.04.001</pub-id><pub-id pub-id-type="pmid">20569810</pub-id></mixed-citation>
</ref>
<ref id="B6">
<label>6.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Morton</surname><given-names>SU</given-names></name><name><surname>Brodsky</surname><given-names>D</given-names></name></person-group>. <article-title>Fetal physiology and the transition to extrauterine life</article-title>. <source/>Clin Perinatol. (<year>2016</year>) <volume>43</volume>:<fpage>395</fpage>–<lpage>407</lpage>. <pub-id pub-id-type="doi">10.1016/j.clp.2016.04.001</pub-id><pub-id pub-id-type="pmid">27524443</pub-id></mixed-citation>
</ref>
<ref id="B7">
<label>7.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wu</surname><given-names>L</given-names></name><name><surname>Liu</surname><given-names>YJ</given-names></name></person-group>. <article-title>Development of dendritic-cell lineages</article-title>. <source/>Immunity. (<year>2007</year>) <volume>26</volume>:<fpage>741</fpage>–<lpage>50</lpage>. <pub-id pub-id-type="doi">10.1016/j.immuni.2007.06.006</pub-id><pub-id pub-id-type="pmid">17582346</pub-id></mixed-citation>
</ref>
<ref id="B8">
<label>8.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Langrish</surname><given-names>CL</given-names></name><name><surname>Buddle</surname><given-names>JC</given-names></name><name><surname>Thrasher</surname><given-names>AJ</given-names></name><name><surname>Goldblatt</surname><given-names>D</given-names></name></person-group>. <article-title>Neonatal dendritic cells are intrinsically biased against Th-1 immune responses</article-title>. <source/>Clin Exp Immunol. (<year>2002</year>) <volume>128</volume>:<fpage>118</fpage>–<lpage>23</lpage>. <pub-id pub-id-type="doi">10.1046/j.1365-2249.2002.01817.x</pub-id><pub-id pub-id-type="pmid">11982599</pub-id></mixed-citation>
</ref>
<ref id="B9">
<label>9.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Willems</surname><given-names>F</given-names></name><name><surname>Vollstedt</surname><given-names>S</given-names></name><name><surname>Suter</surname><given-names>M</given-names></name></person-group>. <article-title>Phenotype and function of neonatal DC</article-title>. <source/>Eur J Immunol. (<year>2009</year>) <volume>39</volume>:<fpage>26</fpage>–<lpage>35</lpage>. <pub-id pub-id-type="doi">10.1002/eji.200838391</pub-id><pub-id pub-id-type="pmid">19137537</pub-id></mixed-citation>
</ref>
<ref id="B10">
<label>10.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Corinti</surname><given-names>S</given-names></name><name><surname>Albanesi</surname><given-names>C</given-names></name><name><surname>la Sala</surname><given-names>A</given-names></name><name><surname>Pastore</surname><given-names>S</given-names></name><name><surname>Girolomoni</surname><given-names>G</given-names></name></person-group>. <article-title>Regulatory activity of autocrine IL-10 on dendritic cell functions</article-title>. <source/>J Immunol. (<year>2001</year>) <volume>166</volume>:<fpage>4312</fpage>–<lpage>8</lpage>. <pub-id pub-id-type="doi">10.4049/jimmunol.166.7.4312</pub-id><pub-id pub-id-type="pmid">11254683</pub-id></mixed-citation>
</ref>
<ref id="B11">
<label>11.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hunt</surname><given-names>DWC</given-names></name><name><surname>Huppertz</surname><given-names>HI</given-names></name><name><surname>Jiang</surname><given-names>HJ</given-names></name><name><surname>Petty</surname><given-names>RE</given-names></name></person-group>. <article-title>Studies of human cord blood dendritic cells: evidence for functional immaturity</article-title>. <source/>Blood. (<year>1994</year>) <volume>84</volume>:<fpage>4333</fpage>–<lpage>43</lpage>. <pub-id pub-id-type="doi">10.1182/blood.V84.12.4333.bloodjournal84124333</pub-id><pub-id pub-id-type="pmid">7994049</pub-id></mixed-citation>
</ref>
<ref id="B12">
<label>12.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Papaioannou</surname><given-names>NE</given-names></name><name><surname>Pasztoi</surname><given-names>M</given-names></name><name><surname>Schraml</surname><given-names>BU</given-names></name></person-group>. <article-title>Understanding the functional properties of neonatal dendritic cells : a doorway to enhance vaccine effectiveness?</article-title>
<source/>Front immunol. (<year>2019</year>) <volume>9</volume>:<fpage>3123</fpage>. <pub-id pub-id-type="doi">10.3389/fimmu.2018.03123</pub-id><pub-id pub-id-type="pmid">30687326</pub-id></mixed-citation>
</ref>
<ref id="B13">
<label>13.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>De Wit</surname><given-names>D</given-names></name><name><surname>Olislagers</surname><given-names>V</given-names></name><name><surname>Goriely</surname><given-names>S</given-names></name><name><surname>Vermeulen</surname><given-names>F</given-names></name><name><surname>Wagner</surname><given-names>H</given-names></name><name><surname>Goldman</surname><given-names>M</given-names></name><etal></etal></person-group>. <article-title>Blood plasmacytoid dendritic cell responses to CpG oligodeoxynucleotides are impaired in human newborns</article-title>. <source/>Blood. (<year>2004</year>) <volume>103</volume>:<fpage>1030</fpage>–<lpage>2</lpage>. <pub-id pub-id-type="doi">10.1182/blood-2003-04-1216</pub-id><pub-id pub-id-type="pmid">14504106</pub-id></mixed-citation>
</ref>
<ref id="B14">
<label>14.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zhang</surname><given-names>X</given-names></name><name><surname>Zhivaki</surname><given-names>D</given-names></name><name><surname>Lo-man</surname><given-names>R</given-names></name></person-group>. <article-title>Unique aspects of the perinatal</article-title>. <source/>Nat Publ Gr. (<year>2017</year>) <volume>17</volume>:<fpage>495</fpage>–<lpage>507</lpage>. <pub-id pub-id-type="doi">10.1038/nri.2017.54</pub-id><pub-id pub-id-type="pmid">28627520</pub-id></mixed-citation>
</ref>
<ref id="B15">
<label>15.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Nguyen</surname><given-names>M</given-names></name><name><surname>Leuridan</surname><given-names>E</given-names></name><name><surname>Zhang</surname><given-names>T</given-names></name><name><surname>De Wit</surname><given-names>D</given-names></name><name><surname>Willems</surname><given-names>F</given-names></name><name><surname>van Damme</surname><given-names>P</given-names></name><etal></etal></person-group>. <article-title>Acquisition of adult-like TLR4 and TLR9 responses during the first year of life</article-title>. <source/>PLoS ONE. (<year>2010</year>) <volume>5</volume>:<fpage>e10407</fpage>. <pub-id pub-id-type="doi">10.1371/journal.pone.0010407</pub-id><pub-id pub-id-type="pmid">20442853</pub-id></mixed-citation>
</ref>
<ref id="B16">
<label>16.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Torok</surname><given-names>C</given-names></name><name><surname>Lundahl</surname><given-names>J</given-names></name><name><surname>Hed</surname><given-names>J</given-names></name><name><surname>Lagercrantz</surname><given-names>H</given-names></name></person-group>. <article-title>Diversity in regulation of adhesion molecules (Mac-1 and L-selectin) in monocytes and neutrophils from neonates and adults</article-title>. <source/>Arch Dis Child. (<year>1993</year>) <volume>68</volume>:<fpage>561</fpage>–<lpage>5</lpage>. <pub-id pub-id-type="doi">10.1136/adc.68.5_Spec_No.561</pub-id><pub-id pub-id-type="pmid">7686738</pub-id></mixed-citation>
</ref>
<ref id="B17">
<label>17.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yerkovich</surname><given-names>ST</given-names></name><name><surname>Wikström</surname><given-names>ME</given-names></name><name><surname>Suriyaarachchi</surname><given-names>D</given-names></name><name><surname>Prescott</surname><given-names>SL</given-names></name><name><surname>Upham</surname><given-names>JW</given-names></name><name><surname>Holt</surname><given-names>PG</given-names></name></person-group>. <article-title>Postnatal development of monocyte cytokine responses to bacterial lipopolysaccharide</article-title>. <source/>Pediatr Res. (<year>2007</year>) <volume>62</volume>:<fpage>547</fpage>–<lpage>52</lpage>. <pub-id pub-id-type="doi">10.1203/PDR.0b013e3181568105</pub-id><pub-id pub-id-type="pmid">17805207</pub-id></mixed-citation>
</ref>
<ref id="B18">
<label>18.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Li</surname><given-names>YP</given-names></name><name><surname>Yu</surname><given-names>SL</given-names></name><name><surname>Huang</surname><given-names>ZJ</given-names></name><name><surname>Huang</surname><given-names>J</given-names></name><name><surname>Pan</surname><given-names>J</given-names></name><name><surname>Feng</surname><given-names>X</given-names></name><etal></etal></person-group>. <article-title>An impaired inflammatory cytokine response to gram-negative LPS in human neonates is associated with the defective TLR-mediated signaling pathway</article-title>. <source/>J Clin Immunol. (<year>2015</year>) <volume>35</volume>:<fpage>218</fpage>–<lpage>26</lpage>. <pub-id pub-id-type="doi">10.1007/s10875-015-0128-6</pub-id><pub-id pub-id-type="pmid">25631527</pub-id></mixed-citation>
</ref>
<ref id="B19">
<label>19.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sharma</surname><given-names>AA</given-names></name><name><surname>Jen</surname><given-names>R</given-names></name><name><surname>Kan</surname><given-names>B</given-names></name><name><surname>Sharma</surname><given-names>A</given-names></name><name><surname>Marchant</surname><given-names>E</given-names></name><name><surname>Tang</surname><given-names>A</given-names></name><etal></etal></person-group>. <article-title>Impaired NLRP3 inflammasome activity during fetal development regulates IL-1β production in human monocytes</article-title>. <source/>Eur J Immunol. (<year>2015</year>) <volume>45</volume>:<fpage>238</fpage>–<lpage>49</lpage>. <pub-id pub-id-type="doi">10.1002/eji.201444707</pub-id><pub-id pub-id-type="pmid">25311115</pub-id></mixed-citation>
</ref>
<ref id="B20">
<label>20.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Leiber</surname><given-names>A</given-names></name><name><surname>Graf</surname><given-names>B</given-names></name><name><surname>Spring</surname><given-names>B</given-names></name><name><surname>Rudner</surname><given-names>J</given-names></name><name><surname>Köstlin</surname><given-names>N</given-names></name><name><surname>Orlikowsky</surname><given-names>TW</given-names></name><etal></etal></person-group>. <article-title>Neonatal monocytes express antiapoptotic pattern of Bcl-2 proteins and show diminished apoptosis upon infection with <italic>Escherichia coli</italic></article-title>. <source/>Pediatr Res. (<year>2014</year>) <volume>76</volume>:<fpage>142</fpage>–<lpage>9</lpage>. <pub-id pub-id-type="doi">10.1038/pr.2014.74</pub-id><pub-id pub-id-type="pmid">24850312</pub-id></mixed-citation>
</ref>
<ref id="B21">
<label>21.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Winterberg</surname><given-names>T</given-names></name><name><surname>Vieten</surname><given-names>G</given-names></name><name><surname>Meier</surname><given-names>T</given-names></name><name><surname>Yu</surname><given-names>Y</given-names></name><name><surname>Busse</surname><given-names>M</given-names></name><name><surname>Hennig</surname><given-names>C</given-names></name><etal></etal></person-group>. <article-title>Distinct phenotypic features of neonatal murine macrophages</article-title>. <source/>Eur J Immunol. (<year>2015</year>) <volume>45</volume>:<fpage>214</fpage>–<lpage>24</lpage>. <pub-id pub-id-type="doi">10.1002/eji.201444468</pub-id><pub-id pub-id-type="pmid">25329762</pub-id></mixed-citation>
</ref>
<ref id="B22">
<label>22.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Angelone</surname><given-names>DF</given-names></name><name><surname>Wessels</surname><given-names>MR</given-names></name><name><surname>Coughlin</surname><given-names>M</given-names></name><name><surname>Suter</surname><given-names>EE</given-names></name><name><surname>Valentini</surname><given-names>P</given-names></name><name><surname>Kalish</surname><given-names>LA</given-names></name><etal></etal></person-group>. <article-title>Innate immunity of the human newborn is polarized toward a high ratio of IL-6/TNF-α production <italic>in vitro</italic> and <italic>in vivo</italic></article-title>. <source/>Pediatr Res. (<year>2006</year>) <volume>60</volume>:<fpage>205</fpage>–<lpage>9</lpage>. <pub-id pub-id-type="doi">10.1203/01.pdr.0000228319.10481.ea</pub-id><pub-id pub-id-type="pmid">16864705</pub-id></mixed-citation>
</ref>
<ref id="B23">
<label>23.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Speer</surname><given-names>CP</given-names></name><name><surname>Gahr</surname><given-names>M</given-names></name><name><surname>Wieland</surname><given-names>M</given-names></name><name><surname>Eber</surname><given-names>S</given-names></name></person-group>. <article-title>Phagocytosis-associated functions in neonatal monocyte-derived macrophages</article-title>. <source/>Pediatr Res. (<year>1988</year>) <volume>24</volume>:<fpage>213</fpage>–<lpage>6</lpage>. <pub-id pub-id-type="doi">10.1203/00006450-198808000-00015</pub-id><pub-id pub-id-type="pmid">2847109</pub-id></mixed-citation>
</ref>
<ref id="B24">
<label>24.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Anderson</surname><given-names>DC</given-names></name><name><surname>Abbassi</surname><given-names>O</given-names></name><name><surname>Kishimoto</surname><given-names>TK</given-names></name><name><surname>Koenig</surname><given-names>JM</given-names></name><name><surname>McIntire</surname><given-names>L V</given-names></name><name><surname>Smith</surname><given-names>CW</given-names></name></person-group>. <article-title>Diminished lectin-, epidermal growth factor-, complement binding domain-cell adhesion molecule-1 on neonatal neutrophils underlies their impaired CD18-independent adhesion to endothelial cells <italic>in vitro</italic></article-title>. <source/>J Immunol. (<year>1991</year>) <volume>146</volume>:<fpage>3372</fpage>–<lpage>9</lpage>. <pub-id pub-id-type="pmid">1709192</pub-id></mixed-citation>
</ref>
<ref id="B25">
<label>25.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Nussbaum</surname><given-names>C</given-names></name><name><surname>Gloning</surname><given-names>A</given-names></name><name><surname>Pruenster</surname><given-names>M</given-names></name><name><surname>Frommhold</surname><given-names>D</given-names></name><name><surname>Bierschenk</surname><given-names>S</given-names></name><name><surname>Genzel-Boroviczeny</surname><given-names>O</given-names></name><etal></etal></person-group>. <article-title>Neutrophil and endothelial adhesive function during human fetal ontogeny</article-title>. <source/>J Leukoc Biol. (<year>2013</year>) <volume>93</volume>:<fpage>175</fpage>–<lpage>84</lpage>. <pub-id pub-id-type="doi">10.1189/jlb.0912468</pub-id><pub-id pub-id-type="pmid">23233729</pub-id></mixed-citation>
</ref>
<ref id="B26">
<label>26.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Weinberger</surname><given-names>B</given-names></name><name><surname>Laskin</surname><given-names>DL</given-names></name><name><surname>Mariano</surname><given-names>TM</given-names></name><name><surname>Sunil</surname><given-names>VR</given-names></name><name><surname>DeCoste</surname><given-names>CJ</given-names></name><name><surname>Heck</surname><given-names>DE</given-names></name><etal></etal></person-group>. <article-title>Mechanisms underlying reduced responsiveness of neonatal neutrophils to distinct chemoattractants</article-title>. <source/>J Leukoc Biol. (<year>2001</year>) <volume>70</volume>:<fpage>969</fpage>–<lpage>76</lpage>. <pub-id pub-id-type="doi">10.1189/jlb.70.6.969</pub-id><pub-id pub-id-type="pmid">11739560</pub-id></mixed-citation>
</ref>
<ref id="B27">
<label>27.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Howard</surname><given-names>TH</given-names></name><name><surname>Meyer</surname><given-names>WH</given-names></name></person-group>. <article-title>Chemotactic peptide modulation of actin assembly and locomotion in neutrophils</article-title>. <source/>J Cell Biol. (<year>1984</year>) <volume>98</volume>:<fpage>1265</fpage>−<lpage>71</lpage>. <pub-id pub-id-type="doi">10.1083/jcb.98.4.1265</pub-id><pub-id pub-id-type="pmid">6232281</pub-id></mixed-citation>
</ref>
<ref id="B28">
<label>28.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Abughali</surname><given-names>N</given-names></name><name><surname>Berger</surname><given-names>M</given-names></name><name><surname>Tosi</surname><given-names>MF</given-names></name></person-group>. <article-title>Deficient total cell content of CR3 (CD11b) in neonatal neutrophils</article-title>. <source/>Blood. (<year>1994</year>) <volume>83</volume>:<fpage>1086</fpage>–<lpage>92</lpage>. <pub-id pub-id-type="doi">10.1182/blood.V83.4.1086.1086</pub-id><pub-id pub-id-type="pmid">7906565</pub-id></mixed-citation>
</ref>
<ref id="B29">
<label>29.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zhu</surname><given-names>J</given-names></name><name><surname>Zhang</surname><given-names>H</given-names></name><name><surname>Guo</surname><given-names>T</given-names></name><name><surname>Li</surname><given-names>W</given-names></name><name><surname>Li</surname><given-names>H</given-names></name><name><surname>Zhu</surname><given-names>Y</given-names></name><etal></etal></person-group>. <article-title>Quantitative proteomics reveals differential biological processes in healthy neonatal cord neutrophils and adult neutrophils</article-title>. <source/>Proteomics. (<year>2014</year>) <volume>14</volume>:<fpage>1688</fpage>–<lpage>97</lpage>. <pub-id pub-id-type="doi">10.1002/pmic.201400009</pub-id><pub-id pub-id-type="pmid">24782442</pub-id></mixed-citation>
</ref>
<ref id="B30">
<label>30.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Dhakal</surname><given-names>M</given-names></name><name><surname>Miller</surname><given-names>MM</given-names></name><name><surname>Zaghouani</surname><given-names>AA</given-names></name><name><surname>Sherman</surname><given-names>MP</given-names></name><name><surname>Zaghouani</surname><given-names>H</given-names></name></person-group>. <article-title>Neonatal basophils stifle the function of early-life dendritic cells to curtail Th1 immunity in newborn mice</article-title>. <source/>J Immunol. (<year>2015</year>) <volume>195</volume>:<fpage>507</fpage>–<lpage>18</lpage>. <pub-id pub-id-type="doi">10.4049/jimmunol.1500027</pub-id><pub-id pub-id-type="pmid">26034171</pub-id></mixed-citation>
</ref>
<ref id="B31">
<label>31.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Guilmot</surname><given-names>A</given-names></name><name><surname>Hermann</surname><given-names>E</given-names></name><name><surname>Braud</surname><given-names>VM</given-names></name><name><surname>Carlier</surname><given-names>Y</given-names></name><name><surname>Truyens</surname><given-names>C</given-names></name></person-group>. <article-title>Natural killer cell responses to infections in early life</article-title>. <source/>J Innate Immun. (<year>2011</year>) <volume>3</volume>:<fpage>280</fpage>–<lpage>8</lpage>. <pub-id pub-id-type="doi">10.1159/000323934</pub-id><pub-id pub-id-type="pmid">21411972</pub-id></mixed-citation>
</ref>
<ref id="B32">
<label>32.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Le</surname><given-names>Garff-Tavernier M</given-names></name><name><surname>Béziat</surname><given-names>V</given-names></name><name><surname>Decocq</surname><given-names>J</given-names></name><name><surname>Siguret</surname><given-names>V</given-names></name><name><surname>Gandjbakhch</surname><given-names>F</given-names></name><name><surname>Pautas</surname><given-names>E</given-names></name><etal></etal></person-group>
<article-title>Human NK cells display major phenotypic and functional changes over the life span</article-title>. <source/>Aging Cell. (<year>2010</year>) <volume>9</volume>:<fpage>527</fpage>–<lpage>35</lpage>. <pub-id pub-id-type="doi">10.1111/j.1474-9726.2010.00584.x</pub-id><pub-id pub-id-type="pmid">20477761</pub-id></mixed-citation>
</ref>
<ref id="B33">
<label>33.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Krampera</surname><given-names>M</given-names></name><name><surname>Tavecchia</surname><given-names>L</given-names></name><name><surname>Benedetti</surname><given-names>F</given-names></name><name><surname>Nadali</surname><given-names>G</given-names></name><name><surname>Pizzolo</surname><given-names>G</given-names></name></person-group>. <article-title>Intracellular cytokine profile of cord blood T-, and NK- cells and monocytes</article-title>. <source/>Haematologica. (<year>2000</year>) <volume>85</volume>:<fpage>675</fpage>–<lpage>9</lpage>. <pub-id pub-id-type="pmid">10897117</pub-id></mixed-citation>
</ref>
<ref id="B34">
<label>34.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kohl</surname><given-names>S</given-names></name><name><surname>Sigouroudinia</surname><given-names>M</given-names></name><name><surname>Engleman</surname><given-names>EG</given-names></name></person-group>. <article-title>Adhesion defects of antibody-mediated target cell binding of neonatal natural killer cells</article-title>. <source/>Pediatr Res. (<year>1999</year>) <volume>46</volume>:<fpage>755</fpage>. <pub-id pub-id-type="doi">10.1203/00006450-199912000-00018</pub-id><pub-id pub-id-type="pmid">10590035</pub-id></mixed-citation>
</ref>
<ref id="B35">
<label>35.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Eberl</surname><given-names>G</given-names></name><name><surname>Colonna</surname><given-names>M</given-names></name><name><surname>Santo</surname><given-names>JP</given-names></name><name><surname>McKenzie</surname><given-names>ANJ</given-names></name></person-group>
<article-title>Innate lymphoid cells: A new paradigm in immunology TL - 348</article-title>. <source/>Innate lymphoid cells A new Paradig Immunol. (<year>1970</year>) <volume>348</volume>:<fpage>aaa6566</fpage>.</mixed-citation>
</ref>
<ref id="B36">
<label>36.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yu</surname><given-names>JC</given-names></name><name><surname>Khodadadi</surname><given-names>H</given-names></name><name><surname>Malik</surname><given-names>A</given-names></name><name><surname>Davidson</surname><given-names>B</given-names></name><name><surname>Yu</surname><given-names>JC</given-names></name></person-group>. <article-title>Innate Immunity of Neonates and Infants</article-title>. <source/>Front Immunol. (<year>2018</year>) <volume>9</volume>:<fpage>1759</fpage>. <pub-id pub-id-type="doi">10.3389/fimmu.2018.01759</pub-id><pub-id pub-id-type="pmid">30105028</pub-id></mixed-citation>
</ref>
<ref id="B37">
<label>37.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bank</surname><given-names>U</given-names></name><name><surname>Deiser</surname><given-names>K</given-names></name><name><surname>Finke</surname><given-names>D</given-names></name><name><surname>Hämmerling</surname><given-names>GJ</given-names></name><name><surname>Arnold</surname><given-names>B</given-names></name><name><surname>Schüler</surname><given-names>T</given-names></name></person-group>. <article-title>Cutting edge: innate lymphoid cells suppress homeostatic T cell expansion in neonatal mice</article-title>. <source/>J Immunol. (<year>2016</year>) <volume>196</volume>:<fpage>3532</fpage>–<lpage>6</lpage>. <pub-id pub-id-type="doi">10.4049/jimmunol.1501643</pub-id><pub-id pub-id-type="pmid">26983785</pub-id></mixed-citation>
</ref>
<ref id="B38">
<label>38.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Baban</surname><given-names>B</given-names></name><name><surname>Malik</surname><given-names>A</given-names></name><name><surname>Bhatia</surname><given-names>J</given-names></name><name><surname>Yu</surname><given-names>JC</given-names></name></person-group>. <article-title>Presence and profile of innate lymphoid cells in human breast milk</article-title>. <source/>JAMA Pediatr. (<year>2018</year>) <volume>172</volume>:<fpage>594</fpage>–<lpage>6</lpage>. <pub-id pub-id-type="doi">10.1001/jamapediatrics.2018.0148</pub-id><pub-id pub-id-type="pmid">29630693</pub-id></mixed-citation>
</ref>
<ref id="B39">
<label>39.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bermick</surname><given-names>JR</given-names></name><name><surname>Lambrecht</surname><given-names>NJ</given-names></name><name><surname>denDekker</surname><given-names>AD</given-names></name><name><surname>Kunkel</surname><given-names>SL</given-names></name><name><surname>Lukacs</surname><given-names>NW</given-names></name><name><surname>Hogaboam</surname><given-names>CM</given-names></name><etal></etal></person-group>. <article-title>Neonatal monocytes exhibit a unique histone modification landscape</article-title>. <source/>Clin Epigenetics. (<year>2016</year>) <volume>8</volume>:<fpage>1</fpage>–<lpage>15</lpage>. <pub-id pub-id-type="doi">10.1186/s13148-016-0265-7</pub-id><pub-id pub-id-type="pmid">26753011</pub-id></mixed-citation>
</ref>
<ref id="B40">
<label>40.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>de Jong</surname><given-names>E</given-names></name><name><surname>Strunk</surname><given-names>T</given-names></name><name><surname>Burgner</surname><given-names>D</given-names></name><name><surname>Lavoie</surname><given-names>PM</given-names></name><name><surname>Currie</surname><given-names>A</given-names></name></person-group>. <article-title>The phenotype and function of preterm infant monocytes: implications for susceptibility to infection</article-title>. <source/>J Leukoc Biol. (<year>2017</year>) <volume>102</volume>:<fpage>645</fpage>–<lpage>56</lpage>. <pub-id pub-id-type="doi">10.1189/jlb.4RU0317-111R</pub-id><pub-id pub-id-type="pmid">28630102</pub-id></mixed-citation>
</ref>
<ref id="B41">
<label>41.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Nash</surname><given-names>MJ</given-names></name><name><surname>Frank</surname><given-names>DN</given-names></name><name><surname>Friedman</surname><given-names>JE</given-names></name></person-group>. <article-title>Early microbes modify immune system development and metabolic homeostasis-the “Restaurant” hypothesis revisited</article-title>. <source/>Front Endocrinol. (<year>2017</year>) <volume>8</volume>:<fpage>349</fpage>. <pub-id pub-id-type="doi">10.3389/fendo.2017.00349</pub-id><pub-id pub-id-type="pmid">29326657</pub-id></mixed-citation>
</ref>
<ref id="B42">
<label>42.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>White</surname><given-names>GP</given-names></name><name><surname>Watt</surname><given-names>PM</given-names></name><name><surname>Holt</surname><given-names>BJ</given-names></name><name><surname>Holt</surname><given-names>PG</given-names></name></person-group>. <article-title>Differential patterns of methylation of the IFN-gamma promoter at CpG and Non-CpG Sites underlie differences in IFN-gamma Gene expression between human neonatal and adult CD45RO- T Cells</article-title>. <source/>J Immunol. (<year>2002</year>) <volume>168</volume>:<fpage>2820</fpage>–<lpage>7</lpage>. <pub-id pub-id-type="doi">10.4049/jimmunol.168.6.2820</pub-id><pub-id pub-id-type="pmid">11884451</pub-id></mixed-citation>
</ref>
<ref id="B43">
<label>43.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cuenca</surname><given-names>AG</given-names></name><name><surname>Wynn</surname><given-names>JL</given-names></name><name><surname>Moldawer</surname><given-names>LL</given-names></name><name><surname>Levy</surname><given-names>O</given-names></name></person-group>. <article-title>Role of innate immunity in neonatal infection</article-title>. <source/>Am J Perinatol. (<year>2013</year>) <volume>30</volume>:<fpage>105</fpage>–<lpage>12</lpage>. <pub-id pub-id-type="doi">10.1055/s-0032-1333412</pub-id><pub-id pub-id-type="pmid">23297181</pub-id></mixed-citation>
</ref>
<ref id="B44">
<label>44.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Dzidic</surname><given-names>M</given-names></name><name><surname>Boix-Amorós</surname><given-names>A</given-names></name><name><surname>Selma-Royo</surname><given-names>M</given-names></name><name><surname>Mira</surname><given-names>A</given-names></name><name><surname>Collado</surname><given-names>M</given-names></name></person-group>. <article-title>Gut microbiota and mucosal immunity in the neonate</article-title>. <source/>Med Sci. (<year>2018</year>) <volume>6</volume>:<fpage>56</fpage>. <pub-id pub-id-type="doi">10.3390/medsci6030056</pub-id><pub-id pub-id-type="pmid">30018263</pub-id></mixed-citation>
</ref>
<ref id="B45">
<label>45.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gensollen</surname><given-names>T</given-names></name><name><surname>Blumberg</surname><given-names>RS</given-names></name></person-group>. <article-title>Correlation between early-life regulation of the immune system by microbiota and allergy development</article-title>. <source/>J Allergy Clin Immunol. (<year>2017</year>) <volume>139</volume>:<fpage>1084</fpage>–<lpage>91</lpage>. <pub-id pub-id-type="doi">10.1016/j.jaci.2017.02.011</pub-id><pub-id pub-id-type="pmid">28390575</pub-id></mixed-citation>
</ref>
<ref id="B46">
<label>46.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gensollen</surname><given-names>T</given-names></name><name><surname>Iyer</surname><given-names>SS</given-names></name><name><surname>Kasper</surname><given-names>DL</given-names></name><name><surname>Blumberg</surname><given-names>RS</given-names></name><name><surname>Medical</surname><given-names>H</given-names></name></person-group>. <article-title>How colonization by microbiota in early life shapes the immune system</article-title>. <source/>Science. (<year>2016</year>) <volume>352</volume>:<fpage>539</fpage>–<lpage>44</lpage>. <pub-id pub-id-type="doi">10.1126/science.aad9378</pub-id><pub-id pub-id-type="pmid">27126036</pub-id></mixed-citation>
</ref>
<ref id="B47">
<label>47.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Thaiss</surname><given-names>CA</given-names></name><name><surname>Zmora</surname><given-names>N</given-names></name><name><surname>Levy</surname><given-names>M</given-names></name><name><surname>Elinav</surname><given-names>E</given-names></name></person-group>. <article-title>The microbiome and innate immunity</article-title>. <source/>Nature. (<year>2016</year>) <volume>535</volume>:<fpage>65</fpage>–<lpage>74</lpage>. <pub-id pub-id-type="doi">10.1038/nature18847</pub-id><pub-id pub-id-type="pmid">27383981</pub-id></mixed-citation>
</ref>
<ref id="B48">
<label>48.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kollmann</surname><given-names>TR</given-names></name><name><surname>Kampmann</surname><given-names>B</given-names></name><name><surname>Mazmanian</surname><given-names>SK</given-names></name><name><surname>Marchant</surname><given-names>A</given-names></name><name><surname>Levy</surname><given-names>O</given-names></name></person-group>. <article-title>Protecting the newborn and young infant from infectious diseases: lessons from immune ontogeny</article-title>. <source/>Immunity. (<year>2017</year>) <volume>46</volume>:<fpage>350</fpage>–<lpage>63</lpage>. <pub-id pub-id-type="doi">10.1016/j.immuni.2017.03.009</pub-id><pub-id pub-id-type="pmid">28329702</pub-id></mixed-citation>
</ref>
<ref id="B49">
<label>49.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Noto</surname><given-names>A</given-names></name><name><surname>Fanos</surname><given-names>V</given-names></name><name><surname>Dessì</surname><given-names>A</given-names></name></person-group>. <article-title>Metabolomics in newborns</article-title>. <source/>Adv Clin Chem. (<year>2016</year>) <volume>74</volume>:<fpage>35</fpage>–<lpage>61</lpage>. <pub-id pub-id-type="doi">10.1016/bs.acc.2015.12.006</pub-id><pub-id pub-id-type="pmid">27117660</pub-id></mixed-citation>
</ref>
<ref id="B50">
<label>50.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Dessi</surname><given-names>A</given-names></name><name><surname>Murgia</surname><given-names>A</given-names></name><name><surname>Agostino</surname><given-names>R</given-names></name><name><surname>Pattumelli</surname><given-names>MG</given-names></name><name><surname>Schirru</surname><given-names>A</given-names></name><name><surname>Scano</surname><given-names>P</given-names></name><etal></etal></person-group>. <article-title>Exploring the role of different neonatal nutrition regimens during the first week of life by urinary GC-MS metabolomics</article-title>. <source/>Int J Mol Sci. (<year>2016</year>) <volume>17</volume>:<fpage>265</fpage>. <pub-id pub-id-type="doi">10.3390/ijms17020265</pub-id><pub-id pub-id-type="pmid">26907266</pub-id></mixed-citation>
</ref>
<ref id="B51">
<label>51.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Reinke</surname><given-names>SN</given-names></name><name><surname>Walsh</surname><given-names>BH</given-names></name><name><surname>Boylan</surname><given-names>GB</given-names></name><name><surname>Sykes</surname><given-names>BD</given-names></name><name><surname>Kenny</surname><given-names>LC</given-names></name><name><surname>Murray</surname><given-names>DM</given-names></name><etal></etal></person-group>. <article-title>1H NMR derived metabolomic profile of neonatal asphyxia in umbilical cord serum: implications for hypoxic ischemic encephalopathy</article-title>. <source/>J Proteome Res. (<year>2013</year>) <volume>12</volume>:<fpage>4230</fpage>–<lpage>9</lpage>. <pub-id pub-id-type="doi">10.1021/pr400617m</pub-id><pub-id pub-id-type="pmid">23931672</pub-id></mixed-citation>
</ref>
<ref id="B52">
<label>52.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Deminice</surname><given-names>R</given-names></name><name><surname>da Silva</surname><given-names>RP</given-names></name><name><surname>Lamarre</surname><given-names>SG</given-names></name><name><surname>Kelly</surname><given-names>KB</given-names></name><name><surname>Jacobs</surname><given-names>RL</given-names></name><name><surname>Brosnan</surname><given-names>ME</given-names></name><etal></etal></person-group>. <article-title>Betaine supplementation prevents fatty liver induced by a high-fat diet: effects on one-carbon metabolism</article-title>. <source/>Amino Acids. (<year>2015</year>) <volume>47</volume>:<fpage>839</fpage>–<lpage>46</lpage>. <pub-id pub-id-type="doi">10.1007/s00726-014-1913-x</pub-id><pub-id pub-id-type="pmid">25577261</pub-id></mixed-citation>
</ref>
<ref id="B53">
<label>53.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Fanos</surname><given-names>V</given-names></name><name><surname>Caboni</surname><given-names>P</given-names></name><name><surname>Corsello</surname><given-names>G</given-names></name><name><surname>Stronati</surname><given-names>M</given-names></name><name><surname>Gazzolo</surname><given-names>D</given-names></name><name><surname>Noto</surname><given-names>A</given-names></name><etal></etal></person-group>. <article-title>Urinary (1)H-NMR and GC-MS metabolomics predicts early and late onset neonatal sepsis</article-title>. <source/>Early Hum Dev. (<year>2014</year>) <volume>90</volume>(<issue>Suppl. 1</issue>):<fpage>S78</fpage>–<lpage>83</lpage>. <pub-id pub-id-type="doi">10.1016/S0378-3782(14)70024-6</pub-id><pub-id pub-id-type="pmid">24709468</pub-id></mixed-citation>
</ref>
<ref id="B54">
<label>54.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Andreas</surname><given-names>NJ</given-names></name><name><surname>Hyde</surname><given-names>MJ</given-names></name><name><surname>Gomez-Romero</surname><given-names>M</given-names></name><name><surname>Lopez-Gonzalvez</surname><given-names>MA</given-names></name><name><surname>Villasenor</surname><given-names>A</given-names></name><name><surname>Wijeyesekera</surname><given-names>A</given-names></name><etal></etal></person-group>. <article-title>Multiplatform characterization of dynamic changes in breast milk during lactation</article-title>. <source/>Electrophoresis. (<year>2015</year>) <volume>36</volume>:<fpage>2269</fpage>–<lpage>85</lpage>. <pub-id pub-id-type="doi">10.1002/elps.201500011</pub-id><pub-id pub-id-type="pmid">25959062</pub-id></mixed-citation>
</ref>
<ref id="B55">
<label>55.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kraus</surname><given-names>WE</given-names></name><name><surname>Muoio</surname><given-names>DM</given-names></name><name><surname>Stevens</surname><given-names>R</given-names></name><name><surname>Craig</surname><given-names>D</given-names></name><name><surname>Bain</surname><given-names>JR</given-names></name><name><surname>Grass</surname><given-names>E</given-names></name><etal></etal></person-group>. <article-title>Metabolomic Quantitative Trait Loci (mQTL) mapping implicates the ubiquitin proteasome system in cardiovascular disease pathogenesis</article-title>. <source/>PLoS Genet. (<year>2015</year>) <volume>11</volume>:<fpage>e1005553</fpage>. <pub-id pub-id-type="doi">10.1371/journal.pgen.1005553</pub-id><pub-id pub-id-type="pmid">26540294</pub-id></mixed-citation>
</ref>
<ref id="B56">
<label>56.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Smith</surname><given-names>PM</given-names></name><name><surname>Howitt</surname><given-names>MR</given-names></name><name><surname>Panikov</surname><given-names>N</given-names></name><name><surname>Michaud</surname><given-names>M</given-names></name><name><surname>Gallini</surname><given-names>CA</given-names></name><name><surname>Bohlooly</surname><given-names>YM</given-names></name><etal></etal></person-group>. <article-title>The microbial metabolites, short-chain fatty acids, regulate colonic treg cell homeostasis</article-title>. <source/>Science. (<year>2013</year>) <volume>341</volume>:<fpage>569</fpage>–<lpage>73</lpage>. <pub-id pub-id-type="doi">10.1126/science.1241165</pub-id><pub-id pub-id-type="pmid">23828891</pub-id></mixed-citation>
</ref>
<ref id="B57">
<label>57.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Blanton</surname><given-names>LV</given-names></name><name><surname>Charbonneau</surname><given-names>MR</given-names></name><name><surname>Salih</surname><given-names>T</given-names></name><name><surname>Barratt</surname><given-names>MJ</given-names></name><name><surname>Venkatesh</surname><given-names>S</given-names></name><name><surname>Ilkaveya</surname><given-names>O</given-names></name><etal></etal></person-group>. <article-title>Gut bacteria that prevent growth impairments transmitted by microbiota from malnourished children</article-title>. <source/>Science. (<year>2016</year>) <volume>351</volume>:<fpage>aad3311</fpage>. <pub-id pub-id-type="doi">10.1126/science.aad3311</pub-id><pub-id pub-id-type="pmid">26912898</pub-id></mixed-citation>
</ref>
<ref id="B58">
<label>58.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kimura</surname><given-names>I</given-names></name><name><surname>Ozawa</surname><given-names>K</given-names></name><name><surname>Inoue</surname><given-names>D</given-names></name><name><surname>Imamura</surname><given-names>T</given-names></name><name><surname>Kimura</surname><given-names>K</given-names></name><name><surname>Maeda</surname><given-names>T</given-names></name><etal></etal></person-group>. <article-title>The gut microbiota suppresses insulin-mediated fat accumulation via the short-chain fatty acid receptor GPR43</article-title>. <source/>Nat Commun. (<year>2013</year>) <volume>4</volume>:<fpage>1829</fpage>. <pub-id pub-id-type="doi">10.1038/ncomms2852</pub-id><pub-id pub-id-type="pmid">23652017</pub-id></mixed-citation>
</ref>
<ref id="B59">
<label>59.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Stewart</surname><given-names>CJ</given-names></name><name><surname>Embleton</surname><given-names>ND</given-names></name><name><surname>Marrs</surname><given-names>ECL</given-names></name><name><surname>Smith</surname><given-names>DP</given-names></name><name><surname>Nelson</surname><given-names>A</given-names></name><name><surname>Abdulkadir</surname><given-names>B</given-names></name><etal></etal></person-group>. <article-title>Temporal bacterial and metabolic development of the preterm gut reveals specific signatures in health and disease</article-title>. <source/>Microbiome. (<year>2016</year>) <volume>4</volume>:<fpage>67</fpage>. <pub-id pub-id-type="doi">10.1186/s40168-016-0216-8</pub-id><pub-id pub-id-type="pmid">28034304</pub-id></mixed-citation>
</ref>
<ref id="B60">
<label>60.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Entner</surname><given-names>N</given-names></name><name><surname>Doudoroff</surname><given-names>M</given-names></name></person-group>. <article-title>Glucose and gluconic acid oxidation of Pseudomonas saccharophila</article-title>. <source/>J Biol Chem. (<year>1952</year>) <volume>196</volume>:<fpage>853</fpage>–<lpage>62</lpage>. <pub-id pub-id-type="pmid">12981024</pub-id></mixed-citation>
</ref>
<ref id="B61">
<label>61.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Simonsen</surname><given-names>KA</given-names></name><name><surname>Anderson-Berry</surname><given-names>AL</given-names></name><name><surname>Delair</surname><given-names>SF</given-names></name><name><surname>Dele Davies</surname><given-names>H</given-names></name></person-group>. <article-title>Early-onset neonatal sepsis</article-title>. <source/>Clin Microbiol Rev. (<year>2014</year>) <volume>27</volume>:<fpage>21</fpage>–<lpage>47</lpage>. <pub-id pub-id-type="doi">10.1128/CMR.00031-13</pub-id><pub-id pub-id-type="pmid">24396135</pub-id></mixed-citation>
</ref>
<ref id="B62">
<label>62.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Camacho-gonzalez</surname><given-names>A</given-names></name><name><surname>Spearman</surname><given-names>PW</given-names></name><name><surname>Diseases</surname><given-names>PI</given-names></name><name><surname>Stoll</surname><given-names>BJ</given-names></name><name><surname>Brumley</surname><given-names>GW</given-names></name><name><surname>Drive</surname><given-names>U</given-names></name></person-group>
<article-title>Neonatal infections disease: evuluation of neonatal sepsis</article-title>. <source/>Pediatr Clin North Am North Am. (<year>2013</year>) <volume>60</volume>:<fpage>367</fpage>–<lpage>89</lpage>. <pub-id pub-id-type="doi">10.1016/j.pcl.2012.12.003</pub-id></mixed-citation>
</ref>
<ref id="B63">
<label>63.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bizzarro</surname><given-names>MJ</given-names></name><name><surname>Raskind</surname><given-names>C</given-names></name><name><surname>Baltimore</surname><given-names>RS</given-names></name><name><surname>Gallagher</surname><given-names>PG</given-names></name></person-group>. <article-title>Seventy-five years of neonatal sepsis at Yale: 1928-2003</article-title>. <source/>Pediatrics. (<year>2005</year>) <volume>116</volume>:<fpage>595</fpage>–<lpage>602</lpage>. <pub-id pub-id-type="doi">10.1542/peds.2005-0552</pub-id><pub-id pub-id-type="pmid">16140698</pub-id></mixed-citation>
</ref>
<ref id="B64">
<label>64.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cancelier</surname><given-names>AC</given-names></name><name><surname>Petronilho</surname><given-names>F</given-names></name><name><surname>Reinke</surname><given-names>A</given-names></name><name><surname>Constantino</surname><given-names>L</given-names></name><name><surname>Machado</surname><given-names>R</given-names></name><name><surname>Ritter</surname><given-names>C</given-names></name><etal></etal></person-group>. <article-title>Inflammatory and oxidative parameters in cord blood as diagnostic of early-onset neonatal sepsis: a case-control study</article-title>. <source/>Pediatr Crit Care Med. (<year>2009</year>) <volume>10</volume>:<fpage>467</fpage>–<lpage>71</lpage>. <pub-id pub-id-type="doi">10.1097/PCC.0b013e318198b0e3</pub-id><pub-id pub-id-type="pmid">19307820</pub-id></mixed-citation>
</ref>
<ref id="B65">
<label>65.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Melvan</surname><given-names>JN</given-names></name><name><surname>Bagby</surname><given-names>GJ</given-names></name><name><surname>Welsh</surname><given-names>DA</given-names></name><name><surname>Nelson</surname><given-names>S</given-names></name><name><surname>Zhang</surname><given-names>P</given-names></name></person-group>. <article-title>Neonatal sepsis and neutrophil insufficiencies</article-title>. <source/>Int Rev Immunol. (<year>2010</year>) <volume>29</volume>:<fpage>315</fpage>–<lpage>48</lpage>. <pub-id pub-id-type="doi">10.3109/08830181003792803</pub-id><pub-id pub-id-type="pmid">20521927</pub-id></mixed-citation>
</ref>
<ref id="B66">
<label>66.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hogasen</surname><given-names>AK</given-names></name><name><surname>Overlie</surname><given-names>I</given-names></name><name><surname>Hansen</surname><given-names>TW</given-names></name><name><surname>Abrahamsen</surname><given-names>TG</given-names></name><name><surname>Finne</surname><given-names>PH</given-names></name><name><surname>Hogasen</surname><given-names>K</given-names></name></person-group>. <article-title>The analysis of the complement activation product SC5 b-9 is applicable in neonates in spite of their profound C9 deficiency</article-title>. <source/>J Perinat Med. (<year>2000</year>) <volume>28</volume>:<fpage>39</fpage>–<lpage>48</lpage>. <pub-id pub-id-type="doi">10.1515/JPM.2000.006</pub-id><pub-id pub-id-type="pmid">10765513</pub-id></mixed-citation>
</ref>
<ref id="B67">
<label>67.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Aikio</surname><given-names>O</given-names></name><name><surname>Vuopala</surname><given-names>K</given-names></name><name><surname>Pokela</surname><given-names>ML</given-names></name><name><surname>Hallman</surname><given-names>M</given-names></name></person-group>. <article-title>Diminished inducible nitric oxide synthase expression in fulminant early-onset neonatal pneumonia</article-title>. <source/>Pediatrics. (<year>2000</year>) <volume>105</volume>:<fpage>1013</fpage>–<lpage>9</lpage>. <pub-id pub-id-type="doi">10.1542/peds.105.5.1013</pub-id><pub-id pub-id-type="pmid">10790456</pub-id></mixed-citation>
</ref>
<ref id="B68">
<label>68.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yost</surname><given-names>CC</given-names></name><name><surname>Cody</surname><given-names>MJ</given-names></name><name><surname>Harris</surname><given-names>ES</given-names></name><name><surname>Thornton</surname><given-names>NL</given-names></name><name><surname>McInturff</surname><given-names>AM</given-names></name><name><surname>Martinez</surname><given-names>ML</given-names></name><etal></etal></person-group>. <article-title>Impaired neutrophil extracellular trap (NET) formation: a novel innate immune deficiency of human neonates</article-title>. <source/>Blood. (<year>2009</year>) <volume>113</volume>:<fpage>6419</fpage>–<lpage>27</lpage>. <pub-id pub-id-type="doi">10.1182/blood-2008-07-171629</pub-id><pub-id pub-id-type="pmid">19221037</pub-id></mixed-citation>
</ref>
<ref id="B69">
<label>69.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Georgeson</surname><given-names>GD</given-names></name><name><surname>Szony</surname><given-names>BJ</given-names></name><name><surname>Streitman</surname><given-names>K</given-names></name><name><surname>Kovács</surname><given-names>A</given-names></name><name><surname>Kovács</surname><given-names>L</given-names></name><name><surname>László</surname><given-names>A</given-names></name></person-group>. <article-title>Natural killer cell cytotoxicity is deficient in newborns with sepsis and recurrent infections</article-title>. <source/>Eur J Pediatr. (<year>2001</year>) <volume>160</volume>:<fpage>478</fpage>–<lpage>82</lpage>. <pub-id pub-id-type="doi">10.1007/s004310100773</pub-id><pub-id pub-id-type="pmid">11548185</pub-id></mixed-citation>
</ref>
<ref id="B70">
<label>70.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Robaina Castellanos</surname><given-names>GR</given-names></name><name><surname>Riesgo Rodriguez</surname><given-names>S</given-names></name><name><surname>de la</surname><given-names>C</given-names></name></person-group>. <article-title>Neonatal sepsis and neurodevelopment in very low birth weight infants in Matanzas, Cuba 2006-2010: a prospective cohort study</article-title>. <source/>Medwave. (<year>2016</year>) <volume>16</volume>:<fpage>e6422</fpage>. <pub-id pub-id-type="doi">10.5867/medwave.2016.02.6422</pub-id><pub-id pub-id-type="pmid">27097362</pub-id></mixed-citation>
</ref>
<ref id="B71">
<label>71.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Fleischmann-Struzek</surname><given-names>C</given-names></name><name><surname>Goldfarb</surname><given-names>DM</given-names></name><name><surname>Schlattmann</surname><given-names>P</given-names></name><name><surname>Schlapbach</surname><given-names>LJ</given-names></name><name><surname>Reinhart</surname><given-names>K</given-names></name><name><surname>Kissoon</surname><given-names>N</given-names></name></person-group>. <article-title>The global burden of paediatric and neonatal sepsis: a systematic review</article-title>. <source/>Lancet Respir Med. (<year>2018</year>) <volume>6</volume>:<fpage>223</fpage>–<lpage>30</lpage>. <pub-id pub-id-type="doi">10.1016/S2213-2600(18)30063-8</pub-id><pub-id pub-id-type="pmid">29508706</pub-id></mixed-citation>
</ref>
<ref id="B72">
<label>72.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ng</surname><given-names>PC</given-names></name></person-group>. <article-title>Diagnostic markers of infection in neonates</article-title>. <source/>Arch Dis Child Fetal Neonatal Ed. (<year>2004</year>) <volume>89</volume>:<fpage>F229</fpage>-<lpage>35</lpage>. <pub-id pub-id-type="doi">10.1136/adc.2002.023838</pub-id><pub-id pub-id-type="pmid">15102726</pub-id></mixed-citation>
</ref>
<ref id="B73">
<label>73.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wu</surname><given-names>YQ</given-names></name><name><surname>Shen</surname><given-names>J</given-names></name><name><surname>Zhou</surname><given-names>QL</given-names></name><name><surname>Zhao</surname><given-names>HW</given-names></name><name><surname>Liu</surname><given-names>LR</given-names></name><name><surname>Liu</surname><given-names>X</given-names></name></person-group>. <article-title>Interleukin-6 and interleukin-8 in diagnosing neonatal septicemia</article-title>. <source/>J Biol Regul Homeost Agents. (<year>2016</year>) <volume>30</volume>:<fpage>1107</fpage>–<lpage>13</lpage>. <pub-id pub-id-type="pmid">28078861</pub-id></mixed-citation>
</ref>
<ref id="B74">
<label>74.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ng</surname><given-names>PC</given-names></name><name><surname>Lam</surname><given-names>HS</given-names></name></person-group>. <article-title>Biomarkers for late-onset neonatal sepsis: cytokines and beyond</article-title>. <source/>Clin Perinatol. (<year>2010</year>) <volume>37</volume>:<fpage>599</fpage>–<lpage>610</lpage>. <pub-id pub-id-type="doi">10.1016/j.clp.2010.05.005</pub-id><pub-id pub-id-type="pmid">20813273</pub-id></mixed-citation>
</ref>
<ref id="B75">
<label>75.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Meadow</surname><given-names>W</given-names></name><name><surname>Rudinsky</surname><given-names>B</given-names></name></person-group>. <article-title>Inflammatory mediators and neonatal sepsis. rarely has so little been known by so many about so much</article-title>. <source/>Clin Perinatol. (<year>1995</year>) <volume>22</volume>:<fpage>519</fpage>–<lpage>36</lpage>. <pub-id pub-id-type="doi">10.1016/S0095-5108(18)30295-1</pub-id><pub-id pub-id-type="pmid">7671549</pub-id></mixed-citation>
</ref>
<ref id="B76">
<label>76.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gomez-Lopez</surname><given-names>N</given-names></name><name><surname>Romero</surname><given-names>R</given-names></name><name><surname>Maymon</surname><given-names>E</given-names></name><name><surname>Kusanovic</surname><given-names>JP</given-names></name><name><surname>Panaitescu</surname><given-names>B</given-names></name><name><surname>Miller</surname><given-names>D</given-names></name><etal></etal></person-group>. <article-title>Clinical chorioamnionitis at term IX: <italic>in vivo</italic> evidence of intra-amniotic inflammasome activation</article-title>. <source/>J Perinat Med. (<year>2019</year>) <volume>47</volume>:<fpage>276</fpage>–<lpage>87</lpage>. <pub-id pub-id-type="doi">10.1515/jpm-2018-0271</pub-id><pub-id pub-id-type="pmid">30412466</pub-id></mixed-citation>
</ref>
<ref id="B77">
<label>77.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kim</surname><given-names>CJ</given-names></name><name><surname>Romero</surname><given-names>R</given-names></name><name><surname>Chaemsaithong</surname><given-names>P</given-names></name><name><surname>Chaiyasit</surname><given-names>N</given-names></name><name><surname>Yoon</surname><given-names>BH</given-names></name><name><surname>Kim</surname><given-names>YM</given-names></name></person-group>. <article-title>Acute chorioamnionitis and funisitis: definition, pathologic features, and clinical significance</article-title>. <source/>Am J Obstet Gynecol. (<year>2015</year>) <volume>213</volume>:<fpage>S29</fpage>–<lpage>52</lpage>. <pub-id pub-id-type="doi">10.1016/j.ajog.2015.08.040</pub-id><pub-id pub-id-type="pmid">26428501</pub-id></mixed-citation>
</ref>
<ref id="B78">
<label>78.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gomez</surname><given-names>R</given-names></name><name><surname>Romero</surname><given-names>R</given-names></name><name><surname>Ghezzi</surname><given-names>F</given-names></name><name><surname>Yoon</surname><given-names>BH</given-names></name><name><surname>Mazor</surname><given-names>M</given-names></name><name><surname>Berry</surname><given-names>SM</given-names></name></person-group>. <article-title>The fetal inflammatory response syndrome</article-title>. <source/>Am J Obstet Gynecol. (<year>1998</year>) <volume>179</volume>:<fpage>194</fpage>–<lpage>202</lpage>. <pub-id pub-id-type="doi">10.1016/S0002-9378(98)70272-8</pub-id><pub-id pub-id-type="pmid">9704787</pub-id></mixed-citation>
</ref>
<ref id="B79">
<label>79.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Boulanger</surname><given-names>LM</given-names></name></person-group>. <article-title>Immune proteins in brain development and synaptic plasticity</article-title>. <source/>Neuron. (<year>2009</year>) <volume>64</volume>:<fpage>93</fpage>–<lpage>109</lpage>. <pub-id pub-id-type="doi">10.1016/j.neuron.2009.09.001</pub-id><pub-id pub-id-type="pmid">19840552</pub-id></mixed-citation>
</ref>
<ref id="B80">
<label>80.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Carpentier</surname><given-names>PA</given-names></name><name><surname>Palmer</surname><given-names>TD</given-names></name></person-group>. <article-title>Immune influence on adult neural stem cell regulation and function</article-title>. <source/>Neuron. (<year>2009</year>) <volume>64</volume>:<fpage>79</fpage>–<lpage>92</lpage>. <pub-id pub-id-type="doi">10.1016/j.neuron.2009.08.038</pub-id><pub-id pub-id-type="pmid">19840551</pub-id></mixed-citation>
</ref>
<ref id="B81">
<label>81.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rainaldi</surname><given-names>MA</given-names></name><name><surname>Perlman</surname><given-names>JM</given-names></name></person-group>. <article-title>Pathophysiology of Birth Asphyxia</article-title>. <source/>Clin Perinatol. (<year>2016</year>) <volume>43</volume>:<fpage>409</fpage>–<lpage>22</lpage>. <pub-id pub-id-type="doi">10.1016/j.clp.2016.04.002</pub-id><pub-id pub-id-type="pmid">27524444</pub-id></mixed-citation>
</ref>
<ref id="B82">
<label>82.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hagberg</surname><given-names>H</given-names></name><name><surname>Mallard</surname><given-names>C</given-names></name><name><surname>Ferriero</surname><given-names>DM</given-names></name><name><surname>Vannucci</surname><given-names>SJ</given-names></name><name><surname>Levison</surname><given-names>SW</given-names></name><name><surname>Vexler</surname><given-names>ZS</given-names></name><etal></etal></person-group>. <article-title>The role of inflammation in perinatal brain injury</article-title>. <source/>Nat Rev Neurol. (<year>2015</year>) <volume>11</volume>:<fpage>192</fpage>–<lpage>208</lpage>. <pub-id pub-id-type="doi">10.1038/nrneurol.2015.13</pub-id><pub-id pub-id-type="pmid">25686754</pub-id></mixed-citation>
</ref>
<ref id="B83">
<label>83.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Aly</surname><given-names>H</given-names></name><name><surname>Khashaba</surname><given-names>MT</given-names></name><name><surname>El-Ayouty</surname><given-names>M</given-names></name><name><surname>El-Sayed</surname><given-names>O</given-names></name><name><surname>Hasanein</surname><given-names>BM</given-names></name></person-group>. <article-title>IL-1beta, IL-6 and TNF-alpha and outcomes of neonatal hypoxic ischemic encephalopathy</article-title>. <source/>Brain Dev. (<year>2006</year>) <volume>28</volume>:<fpage>178</fpage>–<lpage>82</lpage>. <pub-id pub-id-type="doi">10.1016/j.braindev.2005.06.006</pub-id><pub-id pub-id-type="pmid">16181755</pub-id></mixed-citation>
</ref>
<ref id="B84">
<label>84.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chiesa</surname><given-names>C</given-names></name><name><surname>Pellegrini</surname><given-names>G</given-names></name><name><surname>Panero</surname><given-names>A</given-names></name><name><surname>De Luca</surname><given-names>T</given-names></name><name><surname>Assumma</surname><given-names>M</given-names></name><name><surname>Signore</surname><given-names>F</given-names></name><etal></etal></person-group>. <article-title>Umbilical cord interleukin-6 levels are elevated in term neonates with perinatal asphyxia</article-title>. <source/>Eur J Clin Invest. (<year>2003</year>) <volume>33</volume>:<fpage>352</fpage>–<lpage>8</lpage>. <pub-id pub-id-type="doi">10.1046/j.1365-2362.2003.01136.x</pub-id><pub-id pub-id-type="pmid">12662167</pub-id></mixed-citation>
</ref>
<ref id="B85">
<label>85.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Savman</surname><given-names>K</given-names></name><name><surname>Blennow</surname><given-names>M</given-names></name><name><surname>Gustafson</surname><given-names>K</given-names></name><name><surname>Tarkowski</surname><given-names>E</given-names></name><name><surname>Hagberg</surname><given-names>H</given-names></name></person-group>. <article-title>Cytokine response in cerebrospinal fluid after birth asphyxia</article-title>. <source/>Pediatr Res. (<year>1998</year>) <volume>43</volume>:<fpage>746</fpage>–<lpage>51</lpage>. <pub-id pub-id-type="doi">10.1203/00006450-199806000-00006</pub-id><pub-id pub-id-type="pmid">9621983</pub-id></mixed-citation>
</ref>
<ref id="B86">
<label>86.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Okazaki</surname><given-names>K</given-names></name><name><surname>Nishida</surname><given-names>A</given-names></name><name><surname>Kato</surname><given-names>M</given-names></name><name><surname>Kozawa</surname><given-names>K</given-names></name><name><surname>Uga</surname><given-names>N</given-names></name><name><surname>Kimura</surname><given-names>H</given-names></name></person-group>. <article-title>Elevation of cytokine concentrations in asphyxiated neonates</article-title>. <source/>Biol Neonate. (<year>2006</year>) <volume>89</volume>:<fpage>183</fpage>–<lpage>9</lpage>. <pub-id pub-id-type="doi">10.1159/000089180</pub-id><pub-id pub-id-type="pmid">16244469</pub-id></mixed-citation>
</ref>
<ref id="B87">
<label>87.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Morkos</surname><given-names>AA</given-names></name><name><surname>Hopper</surname><given-names>AO</given-names></name><name><surname>Deming</surname><given-names>DD</given-names></name><name><surname>Yellon</surname><given-names>SM</given-names></name><name><surname>Wycliffe</surname><given-names>N</given-names></name><name><surname>Ashwal</surname><given-names>S</given-names></name><etal></etal></person-group>. <article-title>Elevated total peripheral leukocyte count may identify risk for neurological disability in asphyxiated term neonates</article-title>. <source/>J Perinatol. (<year>2007</year>) <volume>27</volume>:<fpage>365</fpage>–<lpage>70</lpage>. <pub-id pub-id-type="doi">10.1038/sj.jp.7211750</pub-id><pub-id pub-id-type="pmid">17443199</pub-id></mixed-citation>
</ref>
<ref id="B88">
<label>88.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Modgil</surname><given-names>S</given-names></name><name><surname>Lahiri</surname><given-names>DK</given-names></name><name><surname>Sharma</surname><given-names>VL</given-names></name><name><surname>Anand</surname><given-names>A</given-names></name></person-group>. <article-title>Role of early life exposure and environment on neurodegeneration: implications on brain disorders</article-title>. <source/>Transl Neurodegener. (<year>2014</year>) <volume>3</volume>:<fpage>9</fpage>. <pub-id pub-id-type="doi">10.1186/2047-9158-3-9</pub-id><pub-id pub-id-type="pmid">24847438</pub-id></mixed-citation>
</ref>
<ref id="B89">
<label>89.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tremlett</surname><given-names>H</given-names></name><name><surname>Bauer</surname><given-names>KC</given-names></name><name><surname>Appel-Cresswell</surname><given-names>S</given-names></name><name><surname>Finlay</surname><given-names>BB</given-names></name><name><surname>Waubant</surname><given-names>E</given-names></name></person-group>. <article-title>The gut microbiome in human neurological disease: a review</article-title>. <source/>Ann Neurol. (<year>2017</year>) <volume>81</volume>:<fpage>369</fpage>–<lpage>82</lpage>. <pub-id pub-id-type="doi">10.1002/ana.24901</pub-id><pub-id pub-id-type="pmid">28220542</pub-id></mixed-citation>
</ref>
<ref id="B90">
<label>90.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gilman</surname><given-names>SE</given-names></name><name><surname>Cherkerzian</surname><given-names>S</given-names></name><name><surname>Buka</surname><given-names>SL</given-names></name><name><surname>Hahn</surname><given-names>J</given-names></name><name><surname>Hornig</surname><given-names>M</given-names></name><name><surname>Goldstein</surname><given-names>JM</given-names></name></person-group>. <article-title>Prenatal immune programming of the sex-dependent risk for major depression</article-title>. <source/>Transl Psychiatry. (<year>2016</year>) <volume>6</volume>:<fpage>e822</fpage>. <pub-id pub-id-type="doi">10.1038/tp.2016.91</pub-id><pub-id pub-id-type="pmid">27244231</pub-id></mixed-citation>
</ref>
<ref id="B91">
<label>91.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Vojdani</surname><given-names>A</given-names></name><name><surname>Mumper</surname><given-names>E</given-names></name><name><surname>Granpeesheh</surname><given-names>D</given-names></name><name><surname>Mielke</surname><given-names>L</given-names></name><name><surname>Traver</surname><given-names>D</given-names></name><name><surname>Bock</surname><given-names>K</given-names></name><etal></etal></person-group>. <article-title>Low natural killer cell cytotoxic activity in autism: the role of glutathione, IL-2 and IL-15</article-title>. <source/>J Neuroimmunol. (<year>2008</year>) <volume>205</volume>:<fpage>148</fpage>–<lpage>54</lpage>. <pub-id pub-id-type="doi">10.1016/j.jneuroim.2008.09.005</pub-id><pub-id pub-id-type="pmid">18929414</pub-id></mixed-citation>
</ref>
<ref id="B92">
<label>92.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ricci</surname><given-names>S</given-names></name><name><surname>Businaro</surname><given-names>R</given-names></name><name><surname>Ippoliti</surname><given-names>F</given-names></name><name><surname>Lo Vasco</surname><given-names>VR</given-names></name><name><surname>Massoni</surname><given-names>F</given-names></name><name><surname>Onofri</surname><given-names>E</given-names></name><etal></etal></person-group>. <article-title>Altered cytokine and BDNF levels in autism spectrum disorder</article-title>. <source/>Neurotox Res. (<year>2013</year>) <volume>24</volume>:<fpage>491</fpage>–<lpage>501</lpage>. <pub-id pub-id-type="doi">10.1007/s12640-013-9393-4</pub-id><pub-id pub-id-type="pmid">23604965</pub-id></mixed-citation>
</ref>
<ref id="B93">
<label>93.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ashwood</surname><given-names>P</given-names></name><name><surname>Krakowiak</surname><given-names>P</given-names></name><name><surname>Hertz-Picciotto</surname><given-names>I</given-names></name><name><surname>Hansen</surname><given-names>R</given-names></name><name><surname>Pessah</surname><given-names>IN</given-names></name><name><surname>Van de Water</surname><given-names>J</given-names></name></person-group>. <article-title>Associations of impaired behaviors with elevated plasma chemokines in autism spectrum disorders</article-title>. <source/>J Neuroimmunol. (<year>2011</year>) <volume>232</volume>:<fpage>196</fpage>–<lpage>9</lpage>. <pub-id pub-id-type="doi">10.1016/j.jneuroim.2010.10.025</pub-id><pub-id pub-id-type="pmid">21095018</pub-id></mixed-citation>
</ref>
<ref id="B94">
<label>94.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Krakowiak</surname><given-names>P</given-names></name><name><surname>Goines</surname><given-names>PE</given-names></name><name><surname>Tancredi</surname><given-names>DJ</given-names></name><name><surname>Ashwood</surname><given-names>P</given-names></name><name><surname>Hansen</surname><given-names>RL</given-names></name><name><surname>Hertz-Picciotto</surname><given-names>I</given-names></name><etal></etal></person-group>. <article-title>Neonatal cytokine profiles associated with autism spectrum disorder</article-title>. <source/>Biol Psychiatry. (<year>2017</year>) <volume>81</volume>:<fpage>442</fpage>–<lpage>51</lpage>. <pub-id pub-id-type="doi">10.1016/j.biopsych.2015.08.007</pub-id><pub-id pub-id-type="pmid">26392128</pub-id></mixed-citation>
</ref>
<ref id="B95">
<label>95.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Saghazadeh</surname><given-names>A</given-names></name><name><surname>Ataeinia</surname><given-names>B</given-names></name><name><surname>Keynejad</surname><given-names>K</given-names></name><name><surname>Abdolalizadeh</surname><given-names>A</given-names></name><name><surname>Hirbod-Mobarakeh</surname><given-names>A</given-names></name><name><surname>Rezaei</surname><given-names>N</given-names></name></person-group>. <article-title>Anti-inflammatory cytokines in autism spectrum disorders: a systematic review and meta-analysis</article-title>. <source/>Cytokine. (<year>2019</year>) <volume>123</volume>:<fpage>154740</fpage>. <pub-id pub-id-type="doi">10.1016/j.cyto.2019.154740</pub-id><pub-id pub-id-type="pmid">31228728</pub-id></mixed-citation>
</ref>
<ref id="B96">
<label>96.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ohja</surname><given-names>K</given-names></name><name><surname>Gozal</surname><given-names>E</given-names></name><name><surname>Fahnestock</surname><given-names>M</given-names></name><name><surname>Cai</surname><given-names>L</given-names></name><name><surname>Cai</surname><given-names>J</given-names></name><name><surname>Freedman</surname><given-names>JH</given-names></name><etal></etal></person-group>. <article-title>Neuroimmunologic and neurotrophic interactions in autism spectrum disorders: relationship to neuroinflammation</article-title>. <source/>Neuromolecular Med. (<year>2018</year>) <volume>20</volume>:<fpage>161</fpage>–<lpage>73</lpage>. <pub-id pub-id-type="doi">10.1007/s12017-018-8488-8</pub-id><pub-id pub-id-type="pmid">29691724</pub-id></mixed-citation>
</ref>
<ref id="B97">
<label>97.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Malik</surname><given-names>M</given-names></name><name><surname>Sheikh</surname><given-names>AM</given-names></name><name><surname>Wen</surname><given-names>G</given-names></name><name><surname>Spivack</surname><given-names>W</given-names></name><name><surname>Brown</surname><given-names>WT</given-names></name><name><surname>Li</surname><given-names>X</given-names></name></person-group>. <article-title>Expression of inflammatory cytokines, Bcl2 and cathepsin D are altered in lymphoblasts of autistic subjects</article-title>. <source/>Immunobiology. (<year>2011</year>) <volume>216</volume>:<fpage>80</fpage>–<lpage>5</lpage>. <pub-id pub-id-type="doi">10.1016/j.imbio.2010.03.001</pub-id><pub-id pub-id-type="pmid">20399529</pub-id></mixed-citation>
</ref>
<ref id="B98">
<label>98.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jenster</surname><given-names>M</given-names></name><name><surname>Bonifacio</surname><given-names>SL</given-names></name><name><surname>Ruel</surname><given-names>T</given-names></name><name><surname>Rogers</surname><given-names>EE</given-names></name><name><surname>Tam</surname><given-names>EW</given-names></name><name><surname>Partridge</surname><given-names>JC</given-names></name><etal></etal></person-group>
<article-title>Maternal or neonatal infection: association with neonatal encephalopathy outcomes</article-title>. <source/>Pediatr Res. (<year>2018</year>) <volume>83</volume>:<fpage>747</fpage>
<pub-id pub-id-type="doi">10.1038/pr.2017.246</pub-id><pub-id pub-id-type="pmid">29658514</pub-id></mixed-citation>
</ref>
<ref id="B99">
<label>99.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Raymond</surname><given-names>SL</given-names></name><name><surname>Stortz</surname><given-names>JA</given-names></name><name><surname>Mira</surname><given-names>JC</given-names></name><name><surname>Larson</surname><given-names>SD</given-names></name><name><surname>Wynn</surname><given-names>JL</given-names></name><name><surname>Moldawer</surname><given-names>LL</given-names></name></person-group>. <article-title>Immunological defects in neonatal sepsis and potential therapeutic approaches</article-title>. <source/>Front Pediatr. (<year>2017</year>) <volume>5</volume>:<fpage>14</fpage>. <pub-id pub-id-type="doi">10.3389/fped.2017.00014</pub-id><pub-id pub-id-type="pmid">28224121</pub-id></mixed-citation>
</ref>
<ref id="B100">
<label>100.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Harbeson</surname><given-names>D</given-names></name><name><surname>Ben-Othman</surname><given-names>R</given-names></name><name><surname>Amenyogbe</surname><given-names>N</given-names></name><name><surname>Kollmann</surname><given-names>TR</given-names></name></person-group>. <article-title>Outgrowing the immaturity myth: the cost of defending from neonatal infectious disease</article-title>. <source/>Front Immunol. (<year>2018</year>) <volume>9</volume>:<fpage>1077</fpage>. <pub-id pub-id-type="doi">10.3389/fimmu.2018.01077</pub-id><pub-id pub-id-type="pmid">29896192</pub-id></mixed-citation>
</ref>
<ref id="B101">
<label>101.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Goodridge</surname><given-names>HS</given-names></name><name><surname>Ahmed</surname><given-names>SS</given-names></name><name><surname>Curtis</surname><given-names>N</given-names></name><name><surname>Kollmann</surname><given-names>TR</given-names></name><name><surname>Levy</surname><given-names>O</given-names></name><name><surname>Netea</surname><given-names>MG</given-names></name><etal></etal></person-group>. <article-title>Harnessing the beneficial heterologous effects of vaccination</article-title>. <source/>Nat Rev Immunol. (<year>2016</year>) <volume>16</volume>:<fpage>392</fpage>–<lpage>400</lpage>. <pub-id pub-id-type="doi">10.1038/nri.2016.43</pub-id><pub-id pub-id-type="pmid">27157064</pub-id></mixed-citation>
</ref>
<ref id="B102">
<label>102.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mateen</surname><given-names>FJ</given-names></name><name><surname>Shinohara</surname><given-names>RT</given-names></name><name><surname>Sutter</surname><given-names>RW</given-names></name></person-group>. <article-title>Oral and inactivated poliovirus vaccines in the newborn: a review</article-title>. <source/>Vaccine. (<year>2013</year>) <volume>31</volume>:<fpage>2517</fpage>–<lpage>24</lpage>. <pub-id pub-id-type="doi">10.1016/j.vaccine.2012.06.020</pub-id><pub-id pub-id-type="pmid">22728224</pub-id></mixed-citation>
</ref>
<ref id="B103">
<label>103.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Traudt</surname><given-names>CM</given-names></name><name><surname>McPherson</surname><given-names>RJ</given-names></name><name><surname>Bauer</surname><given-names>LA</given-names></name><name><surname>Richards</surname><given-names>TL</given-names></name><name><surname>Burbacher</surname><given-names>TM</given-names></name><name><surname>McAdams</surname><given-names>RM</given-names></name><etal></etal></person-group>. <article-title>Concurrent erythropoietin and hypothermia treatment improve outcomes in a term nonhuman primate model of perinatal asphyxia</article-title>. <source/>Dev Neurosci. (<year>2013</year>) <volume>35</volume>:<fpage>491</fpage>–<lpage>503</lpage>. <pub-id pub-id-type="doi">10.1159/000355460</pub-id><pub-id pub-id-type="pmid">24192275</pub-id></mixed-citation>
</ref>
<ref id="B104">
<label>104.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Robertson</surname><given-names>NJ</given-names></name><name><surname>Faulkner</surname><given-names>S</given-names></name><name><surname>Fleiss</surname><given-names>B</given-names></name><name><surname>Bainbridge</surname><given-names>A</given-names></name><name><surname>Andorka</surname><given-names>C</given-names></name><name><surname>Price</surname><given-names>D</given-names></name><etal></etal></person-group>. <article-title>Melatonin augments hypothermic neuroprotection in a perinatal asphyxia model</article-title>. <source/>Brain. (<year>2013</year>) <volume>136</volume>:<fpage>90</fpage>–<lpage>105</lpage>. <pub-id pub-id-type="doi">10.1093/brain/aws285</pub-id><pub-id pub-id-type="pmid">23183236</pub-id></mixed-citation>
</ref>
<ref id="B105">
<label>105.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Aden</surname><given-names>U</given-names></name><name><surname>Favrais</surname><given-names>G</given-names></name><name><surname>Plaisant</surname><given-names>F</given-names></name><name><surname>Winerdal</surname><given-names>M</given-names></name><name><surname>Felderhoff-Mueser</surname><given-names>U</given-names></name><name><surname>Lampa</surname><given-names>J</given-names></name><etal></etal></person-group>. <article-title>Systemic inflammation sensitizes the neonatal brain to excitotoxicity through a pro-/anti-inflammatory imbalance: key role of TNFalpha pathway and protection by etanercept</article-title>. <source/>Brain Behav Immun. (<year>2010</year>) <volume>24</volume>:<fpage>747</fpage>–<lpage>58</lpage>. <pub-id pub-id-type="doi">10.1016/j.bbi.2009.10.010</pub-id><pub-id pub-id-type="pmid">19861157</pub-id></mixed-citation>
</ref>
<ref id="B106">
<label>106.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Girard</surname><given-names>S</given-names></name><name><surname>Sebire</surname><given-names>H</given-names></name><name><surname>Brochu</surname><given-names>ME</given-names></name><name><surname>Briota</surname><given-names>S</given-names></name><name><surname>Sarret</surname><given-names>P</given-names></name><name><surname>Sebire</surname><given-names>G</given-names></name></person-group>
<article-title>Postnatal administration of IL-1Ra exerts neuroprotective effects following perinatal inflammation and/or hypoxic-ischemic injuries</article-title>. <source/>Brain Behav Immun. (<year>2012</year>) <volume>26</volume>:<fpage>1331</fpage>–<lpage>9</lpage>. <pub-id pub-id-type="doi">10.1016/j.bbi.2012.09.001</pub-id><pub-id pub-id-type="pmid">22982341</pub-id></mixed-citation>
</ref>
<ref id="B107">
<label>107.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Feng</surname><given-names>Y</given-names></name><name><surname>Rhodes</surname><given-names>PG</given-names></name><name><surname>Bhatt</surname><given-names>AJ</given-names></name></person-group>. <article-title>Dexamethasone pre-treatment protects brain against hypoxic-ischemic injury partially through up-regulation of vascular endothelial growth factor A in neonatal rats</article-title>. <source/>Neuroscience. (<year>2011</year>) <volume>179</volume>:<fpage>223</fpage>–<lpage>32</lpage>. <pub-id pub-id-type="doi">10.1016/j.neuroscience.2011.01.050</pub-id><pub-id pub-id-type="pmid">21277350</pub-id></mixed-citation>
</ref>
</ref-list>
<glossary>
<def-list>
<title>Abbreviations</title>
<def-item>
<term>DCs</term>
<def>
<p>dendritic cells</p>
</def>
</def-item>
<def-item>
<term>cDCs</term>
<def>
<p>conventional dendritic cells</p>
</def>
</def-item>
<def-item>
<term>pDCs</term>
<def>
<p>plasmacytoid dendritic cells</p>
</def>
</def-item>
<def-item>
<term>LPS</term>
<def>
<p>lipopolysaccharide</p>
</def>
</def-item>
<def-item>
<term>Th1</term>
<def>
<p>T helper type 1</p>
</def>
</def-item>
<def-item>
<term>PRRs</term>
<def>
<p>pattern recognition receptors</p>
</def>
</def-item>
<def-item>
<term>TLR</term>
<def>
<p>Toll-like receptor</p>
</def>
</def-item>
<def-item>
<term>CpG</term>
<def>
<p>cytosine-phosphate-guanosine</p>
</def>
</def-item>
<def-item>
<term>PI:C</term>
<def>
<p>polyinosinic-polycytidylic acid</p>
</def>
</def-item>
<def-item>
<term>PGN</term>
<def>
<p>peptidoglycan</p>
</def>
</def-item>
<def-item>
<term>HSV</term>
<def>
<p>herpes simplex virus</p>
</def>
</def-item>
<def-item>
<term>HLA-DR</term>
<def>
<p>human leukocyte antigen-DR isotype</p>
</def>
</def-item>
<def-item>
<term>BCL-2</term>
<def>
<p>B-cell lymphoma 2</p>
</def>
</def-item>
<def-item>
<term>MAPK</term>
<def>
<p>mitogen-activated protein kinase</p>
</def>
</def-item>
<def-item>
<term>NLRP3</term>
<def>
<p>nucleotide-binding domain and leucine-rich repeat containing protein 3</p>
</def>
</def-item>
<def-item>
<term>NETs</term>
<def>
<p>neutrophil extracellular traps</p>
</def>
</def-item>
<def-item>
<term>NK</term>
<def>
<p>natural killer</p>
</def>
</def-item>
<def-item>
<term>ILCs</term>
<def>
<p>Innate Lymphoid Cells</p>
</def>
</def-item>
<def-item>
<term>NEC</term>
<def>
<p>necrotizing enterocolitis</p>
</def>
</def-item>
<def-item>
<term>EOS</term>
<def>
<p>early-onset sepsis</p>
</def>
</def-item>
<def-item>
<term>LOS</term>
<def>
<p>late-onset sepsis</p>
</def>
</def-item>
<def-item>
<term>HI</term>
<def>
<p>hypoxia-ischemia</p>
</def>
</def-item>
<def-item>
<term>HIE</term>
<def>
<p>hypoxic-ischemic encephalopathy</p>
</def>
</def-item>
<def-item>
<term>CSF</term>
<def>
<p>cerebrospinal fluid</p>
</def>
</def-item>
<def-item>
<term>ASD</term>
<def>
<p>autism spectrum disorders.</p>
</def>
</def-item>
</def-list>
</glossary>
</back>
</article>
</pmc-articleset>